| Juniper (telehealth company) | 100.0 | 6 | 4 |
| Cora Health | 61.2 | 2 | 2 |
| WW International | 38.6 | 1 | 1 |
| Obesity Medicine Association | 38.6 | 1 | 1 |
| Noom | 38.6 | 1 | 1 |
| Profile Plan | 38.6 | 1 | 1 |
| Effects of breakfast eating and eating frequency on body mass index and weight loss outcomes in adults enrolled in an obesity treatment program | 34.5 | 0 | 3 |
| Weight Loss for Uncontrolled Asthma Associated With Elevated BMI | 34.5 | 0 | 3 |
| Massachusetts General Hospital | 33.9 | 2 | 0 |
| Yale School of Medicine | 33.9 | 2 | 0 |
| Cleveland Clinic | 33.9 | 2 | 0 |
| Everyday Health | 33.9 | 2 | 0 |
| Live Science | 33.9 | 2 | 0 |
| UCLA Health System | 33.9 | 2 | 0 |
| Oregon Graduate Center | 33.9 | 2 | 0 |
| Axios | 33.9 | 2 | 0 |
| Forbes 30 Under 30 | 33.9 | 2 | 0 |
| Mayo Clinic Health System | 33.9 | 2 | 0 |
| Johns Hopkins Medicine | 33.9 | 2 | 0 |
| University of Pennsylvania Division of Endocrinology, Diabetes and Metabolism | 33.9 | 2 | 0 |
| Forbes ASAP | 33.9 | 2 | 0 |
| Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity | 33.9 | 2 | 0 |
| Forbes Best-In-State Wealth Advisor | 33.9 | 2 | 0 |
| Forbes Top 250 Wealth Advisor | 33.9 | 2 | 0 |
| Jenny Craig, Inc. | 27.3 | 0 | 2 |
| Weight loss camp | 27.3 | 0 | 2 |
| The effects of two workplace weight management programs and weight loss on health care utilization and costs | 27.3 | 0 | 2 |
| Through Thick and Thin: Identifying Barriers to Bariatric Surgery, Weight Loss Maintenance, and Tailoring Obesity Treatment for the Future | 27.3 | 0 | 2 |
| A clinical perspective of obesity, metabolic syndrome and cardiovascular disease | 27.3 | 0 | 2 |
| A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus | 27.3 | 0 | 2 |
| GLP-1 receptor agonists: a review of head-to-head clinical studies | 27.3 | 0 | 2 |
| Where are family theories in family-based obesity treatment?: conceptualizing the study of families in pediatric weight management | 27.3 | 0 | 2 |
| Barriers to and Facilitators of Long Term Weight Loss Maintenance in Adult UK People: A Thematic Analysis | 27.3 | 0 | 2 |
| Novel α-MSH analog causes weight loss in obese rats and minipigs and improves insulin sensitivity | 27.3 | 0 | 2 |
| A systematic review of medicinal plants used for weight loss in Brazil: Is there potential for obesity treatment? | 27.3 | 0 | 2 |
| Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients | 27.3 | 0 | 2 |
| Low-fat versus low-carbohydrate weight reduction diets: effects on weight loss, insulin resistance, and cardiovascular risk: a randomized control trial. | 27.3 | 0 | 2 |
| Insights from the POWER practice-based weight loss trial: a focus group study on the PCP's role in weight management | 27.3 | 0 | 2 |
| The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss | 27.3 | 0 | 2 |
| Equivalent weight loss for weight management programs delivered by phone and clinic | 27.3 | 0 | 2 |
| Serum levels of tumour necrosis factor-alpha and interleukin-6 and their correlation with body mass index, weight loss, appetite and survival rate--preliminary data of Viennese outpatients with metastatic cancer during palliative chemotherapy | 27.3 | 0 | 2 |
| The Most Popular Smartphone Apps for Weight Loss: A Quality Assessment | 27.3 | 0 | 2 |
| Effectiveness of a new dietetic weight management food to achieve weight loss in client-owned obese cats | 27.3 | 0 | 2 |
| Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). | 27.3 | 0 | 2 |
| At which body mass index and degree of weight loss should hospitalized elderly patients be considered at nutritional risk? | 27.3 | 0 | 2 |
| Dipeptidyl peptidase‐4 inhibitors are effective in Japanese type 2 diabetic patients with sustained endogenous insulin‐secreting capacity, a higher body mass index and insulin resistance | 27.3 | 0 | 2 |
| Evaluation of a multiprofessional, nonsurgical obesity treatment program: which parameters indicated life style changes and weight loss? | 27.3 | 0 | 2 |
| Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss. | 27.3 | 0 | 2 |
| The association between hematological parameters and insulin resistance is modified by body mass index - results from the North-East Italy MoMa population study | 27.3 | 0 | 2 |
| Relationship between body mass index and insulin resistance in patients treated with second generation antipsychotic agents | 27.3 | 0 | 2 |
| PDA+: A Personal Digital Assistant for Obesity Treatment - an RCT testing the use of technology to enhance weight loss treatment for veterans | 27.3 | 0 | 2 |
| Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. | 27.3 | 0 | 2 |
| Insulin resistance syndrome, body mass index and the risk of ischemic heart disease | 27.3 | 0 | 2 |
| Tailoring dietary approaches for weight loss | 27.3 | 0 | 2 |
| Dietary weight loss and exercise effects on insulin resistance in postmenopausal women | 27.3 | 0 | 2 |
| Postoperative Body Mass Index Changes in Gastric Cancer Patients according to Reconstruction Type: Effectiveness of Long Jejunal Bypass on Weight Loss in Obese Patients after Distal Gastrectomy | 27.3 | 0 | 2 |
| Should providers encourage realistic weight expectations and satisfaction with lost weight in commercial weight loss programs? a preliminary study | 27.3 | 0 | 2 |
| A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys | 27.3 | 0 | 2 |
| Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques | 27.3 | 0 | 2 |
| Body mass index-independent inflammation in omental adipose tissue associated with insulin resistance in morbid obesity | 27.3 | 0 | 2 |
| Ascending dose-controlled trial of beloranib, a novel obesity treatment for safety, tolerability, and weight loss in obese women. | 27.3 | 0 | 2 |
| Effect of a 12-week weight management program on the clinical characteristics and dietary intake of the young obese and the contributing factors to the successful weight loss | 27.3 | 0 | 2 |
| Impaired Cross-Talk between Mesolimbic Food Reward Processing and Metabolic Signaling Predicts Body Mass Index | 27.3 | 0 | 2 |
| Acne: Risk Indicator for Increased Body Mass Index and Insulin Resistance | 27.3 | 0 | 2 |
| Is waist circumference a better predictor of blood pressure, insulin resistance and blood lipids than body mass index in young Chilean adults? | 27.3 | 0 | 2 |
| Correlation between reduction of superior interventricular groove epicardial fat thickness and improvement of insulin resistance after weight loss in obese men. | 27.3 | 0 | 2 |
| Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance | 27.3 | 0 | 2 |
| Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss. | 27.3 | 0 | 2 |
| Varying protein source and quantity do not significantly improve weight loss, fat loss, or satiety in reduced energy diets among midlife adults | 27.3 | 0 | 2 |
| Risk of adverse pregnancy outcomes by prepregnancy body mass index: a population-based study to inform prepregnancy weight loss counseling | 27.3 | 0 | 2 |
| The influence of calcium supplement on body composition, weight loss and insulin resistance in obese adults receiving low calorie diet. | 27.3 | 0 | 2 |
| Shaking Up the System: The Role of Change in Maternal-Adolescent Communication Quality and Adolescent Weight Loss | 27.3 | 0 | 2 |
| Demographic profile, clinical characteristics, motivations and weight loss outcomes of patients in a nonsurgical weight management programme | 27.3 | 0 | 2 |
| Insulin resistance influences weight loss in non-obese women who followed a home-based exercise program and slight caloric restriction | 27.3 | 0 | 2 |
| Differential effects of exposure to maternal obesity or maternal weight loss during the periconceptional period in the sheep on insulin signalling molecules in skeletal muscle of the offspring at 4 months of age. | 27.3 | 0 | 2 |
| Autophagy: A housekeeper in cardiorenal metabolic health and disease | 27.3 | 0 | 2 |
| Social embeddedness in an online weight management programme is linked to greater weight loss. | 27.3 | 0 | 2 |
| Investigation of insulin resistance in narcoleptic patients: dependent or independent of body mass index? | 27.3 | 0 | 2 |
| Is Waist Circumference a Better Predictor of Insulin Resistance Than Body Mass Index in U.S. Adolescents? | 27.3 | 0 | 2 |
| Using personality as a predictor of diet induced weight loss and weight management | 27.3 | 0 | 2 |
| The potential of phototherapy to reduce body fat, insulin resistance and "metabolic inflexibility" related to obesity in women undergoing weight loss treatment | 27.3 | 0 | 2 |
| Influence of weight loss and physical activity interventions upon muscle lipid content in relation to insulin resistance | 27.3 | 0 | 2 |
| Evaluation of effect of body mass index and weight loss on survival of patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy | 27.3 | 0 | 2 |
| Associations among Body Mass Index, Insulin Resistance, and Pancreatic β-Cell Function in Korean Patients with New-Onset Type 2 Diabetes | 27.3 | 0 | 2 |
| Effects of Weight Loss Speed on Kidney Function Differ Depending on Body Mass Index in Nondiabetic Healthy People: A Prospective Cohort | 27.3 | 0 | 2 |
| Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study | 27.3 | 0 | 2 |
| Weight Loss and Decrease of Body Mass Index during Allogeneic Stem Cell Transplantation Are Common Events with Limited Clinical Impact | 27.3 | 0 | 2 |
| A qualitative study exploring why adults with intellectual disabilities and obesity want to lose weight and views of their carers | 27.3 | 0 | 2 |
| Body mass index and insulin resistance | 27.3 | 0 | 2 |
| Estimating the proportion of metabolic health outcomes attributable to obesity: a cross-sectional exploration of body mass index and waist circumference combinations | 27.3 | 0 | 2 |
| Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals | 27.3 | 0 | 2 |
| What change in body mass index is needed to improve metabolic health status in childhood obesity: protocol for a systematic review | 27.3 | 0 | 2 |
| Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats | 27.3 | 0 | 2 |
| Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss | 27.3 | 0 | 2 |
| Safety and efficacy of a side-to-side duodeno-ileal anastomosis for weight loss and type-2 diabetes: duodenal bipartition, a novel metabolic surgery procedure | 27.3 | 0 | 2 |
| Glucose tolerance, insulin resistance and insulin secretion in young south Indian adults: Relationships to parental size, neonatal size and childhood body mass index | 27.3 | 0 | 2 |
| Associations of body mass index and insulin resistance with leptin, adiponectin, and the leptin-to-adiponectin ratio across ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). | 27.3 | 0 | 2 |
| Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK | 27.3 | 0 | 2 |
| Replication and meta-analysis of the gene-environment interaction between body mass index and the interleukin-6 promoter polymorphism with higher insulin resistance | 27.3 | 0 | 2 |
| A review: which dietary plan is best for your patients seeking weight loss and sustained weight management? | 27.3 | 0 | 2 |
| The Influence of Sleep Disordered Breathing on Weight Loss in a National Weight Management Program | 27.3 | 0 | 2 |
| Increased vegetable and fruit consumption during weight loss effort correlates with increased weight and fat loss | 27.3 | 0 | 2 |
| Lifestyle patterns associated with diet, physical activity, body mass index and amount of recent weight loss in a sample of successful weight losers | 27.3 | 0 | 2 |
| GLP-1 receptor agonists: Nonglycemic clinical effects in weight loss and beyond. | 27.3 | 0 | 2 |
| Impact of Insulin Resistance, Body Mass Index, Disease Duration, and Duration of Metformin Use on the Efficacy of Vildagliptin | 27.3 | 0 | 2 |
| Weight Loss and Body Mass Index as Predictors of HIV Disease Progression to AIDS in Adults. Aquitaine Cohort, France, 1985–1997 | 27.3 | 0 | 2 |
| An investigation of the associations among sleep duration and quality, body mass index and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. | 27.3 | 0 | 2 |
| Association between thyroid hormone levels and insulin resistance and body mass index | 27.3 | 0 | 2 |
| The association between body mass index, weight loss and physical function in the year following a hip fracture | 27.3 | 0 | 2 |
| A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance | 27.3 | 0 | 2 |
| Effects of clinically significant weight loss with exercise training on insulin resistance and cardiometabolic adaptations | 27.3 | 0 | 2 |
| Can early weight loss, eating behaviors and socioeconomic factors predict successful weight loss at 12- and 24-months in adolescents with obesity and insulin resistance participating in a randomised controlled trial? | 27.3 | 0 | 2 |
| Obesogenic memory can confer long-term increases in adipose tissue but not liver inflammation and insulin resistance after weight loss | 27.3 | 0 | 2 |
| Effects of Diet Composition and Insulin Resistance Status on Plasma Lipid Levels in a Weight Loss Intervention in Women | 27.3 | 0 | 2 |
| Branched-chain amino acid levels are associated with improvement in insulin resistance with weight loss | 27.3 | 0 | 2 |
| Effect of preoperative body mass index on weight loss after obesity surgery | 27.3 | 0 | 2 |
| Genetic susceptibility to diabetes and long-term improvement of insulin resistance and β cell function during weight loss: the Preventing Overweight Using Novel Dietary Strategies (POUNDS LOST) trial | 27.3 | 0 | 2 |
| Changes in Weight Loss, Health Behaviors, and Intentions among 400 Participants Who Dropped out from an Insurance-Sponsored, Community-Based Weight Management Program | 27.3 | 0 | 2 |
| Adherence to GLP-1 receptor agonist therapy administered by once-daily or once-weekly injection in patients with type 2 diabetes in Germany | 27.3 | 0 | 2 |
| Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss | 27.3 | 0 | 2 |
| Strength Training Prevents Hyperinsulinemia, Insulin Resistance, and Inflammation Independent of Weight Loss in Fructose-Fed Animals | 27.3 | 0 | 2 |
| The association between rate of initial weight loss and long-term success in obesity treatment: does slow and steady win the race? | 27.3 | 0 | 2 |
| Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care | 27.3 | 0 | 2 |
| Relationship of food addiction to weight loss and attrition during obesity treatment. | 27.3 | 0 | 2 |
| Improvement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months' consumption of a combination of bioactive food ingredients in overweight subjects | 27.3 | 0 | 2 |
| Contributions of weight perceptions to weight loss attempts: differences by body mass index and gender | 27.3 | 0 | 2 |
| Sex differences in the associations of visceral adiposity, homeostatic model assessment of insulin resistance, and body mass index with lipoprotein subclass analysis in obese adolescents | 27.3 | 0 | 2 |
| Body mass index predicts insulin resistance in survivors of pediatric acute lymphoblastic leukemia | 27.3 | 0 | 2 |
| Effects of weight loss and exercise on insulin resistance, and intramyocellular triacylglycerol, diacylglycerol and ceramide. | 27.3 | 0 | 2 |
| Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss | 27.3 | 0 | 2 |
| Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index | 27.3 | 0 | 2 |
| Body mass index, weight loss, and mortality in community-dwelling older adults. | 27.3 | 0 | 2 |
| Evaluation of attendance and weight loss in an intensive weight management clinic compared to standard dietetic care | 27.3 | 0 | 2 |
| Setting targets leads to greater long-term weight losses and 'unrealistic' targets increase the effect in a large community-based commercial weight management group | 27.3 | 0 | 2 |
| Does Regular Exercise without Weight Loss Reduce Insulin Resistance in Children and Adolescents? | 27.3 | 0 | 2 |
| Adherence and weight loss outcomes associated with food-exercise diary preference in a military weight management program | 27.3 | 0 | 2 |
| Relationship of Early Pregnancy Waist-to-Hip Ratio versus Body Mass Index with Gestational Diabetes Mellitus and Insulin Resistance | 27.3 | 0 | 2 |
| Non-alcoholic fatty liver disease may develop in individuals with normal body mass index | 27.3 | 0 | 2 |
| Proposed role of calcium and dairy food components in weight management and metabolic health | 27.3 | 0 | 2 |
| Predictors of weight loss maintenance following an insurance-sponsored weight management program | 27.3 | 0 | 2 |
| Exercise, appetite and weight management: understanding the compensatory responses in eating behaviour and how they contribute to variability in exercise-induced weight loss | 27.3 | 0 | 2 |
| Prevalence and Measures of Nutritional Compromise Among Nursing Home Patients: Weight Loss, Low Body Mass Index, Malnutrition, and Feeding Dependency, A Systematic Review of the Literature | 27.3 | 0 | 2 |
| Breast reconstruction with abdominal-based free flaps in high body mass index population: postoperative complications and impact of weight loss | 27.3 | 0 | 2 |
| Roux-en-Y gastric bypass after successful weight loss with a laparoscopic adjustable gastric band: rationales and early outcomes in patients of body mass index<35 kg/m2 | 27.3 | 0 | 2 |
| GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus: Recent Developments and Emerging Agents | 27.3 | 0 | 2 |
| Updates in weight loss surgery and gastrointestinal peptides | 27.3 | 0 | 2 |
| A multicomponent nutrient bar promotes weight loss and improves dyslipidemia and insulin resistance in the overweight/obese: chronic inflammation blunts these improvements | 27.3 | 0 | 2 |
| Extremes of weight gain and weight loss with detailed assessments of energy balance: Illustrative case studies and clinical recommendations | 27.3 | 0 | 2 |
| Visceral fat area as a new predictor of short-term diabetes remission after Roux-en-Y gastric bypass surgery in Chinese patients with a body mass index less than 35 kg/m2 | 27.3 | 0 | 2 |
| Increased frequency of dietitian visits is associated with improved body mass index outcomes in obese youth participating in a comprehensive pediatric weight management program. | 27.3 | 0 | 2 |
| Effects of meal frequency on weight loss and body composition: a meta-analysis | 27.3 | 0 | 2 |
| Weight management practices and evidence for weight loss through primary care: a brief review | 27.3 | 0 | 2 |
| Differential effects of prandial and non-prandial GLP-1 receptor agonists in type 2 diabetes therapy | 27.3 | 0 | 2 |
| An overview of new GLP-1 receptor agonists for type 2 diabetes | 27.3 | 0 | 2 |
| The Whitening of Brown Fat and Its Implications for Weight Management in Obesity | 27.3 | 0 | 2 |
| Is Endoluminal Bariatric Therapy a New Paradigm of Treatment for Obesity? | 27.3 | 0 | 2 |
| Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis. | 27.3 | 0 | 2 |
| Effect of a community-based weight management program on weight loss and cardiovascular disease risk factors | 27.3 | 0 | 2 |
| Apolipoprotein E4, Gender, Body Mass Index, Inflammation, Insulin Resistance, and Air Pollution Interactions: Recipe for Alzheimer's Disease Development in Mexico City Young Females | 27.3 | 0 | 2 |
| Evaluation of Body Mass Index (BMI) Percentile cut-off Levels with Reference to Insulin Resistance: A Comparative Study on South Indian Obese and Non–Obese Adolescents | 27.3 | 0 | 2 |
| The future of obesity treatment: comment on "Integrating technology into standard weight loss treatment: a randomized controlled trial". | 27.3 | 0 | 2 |
| Sex Differences in Weight Loss among Veterans with Serious Mental Illness: Observational Study of a National Weight Management Program. | 27.3 | 0 | 2 |
| Association Between Maternal Prepregnancy Body Mass Index and Plasma Folate Concentrations With Child Metabolic Health | 27.3 | 0 | 2 |
| Usefulness of Baltasar's expected body mass index as an indicator of bariatric weight loss surgery | 27.3 | 0 | 2 |
| Lipoprotein metabolism, insulin resistance, and adipocytokine levels in Japanese female adolescents with a normal body mass index and high body fat mass. | 27.3 | 0 | 2 |
| Impact of hypovitaminosis D on clinical, hormonal and insulin sensitivity parameters in normal body mass index polycystic ovary syndrome women | 27.3 | 0 | 2 |
| Sex differences in the relation of weight loss self-efficacy, binge eating, and depressive symptoms to weight loss success in a residential obesity treatment program | 27.3 | 0 | 2 |
| Body contouring procedures in three or more anatomical areas are associated with long-term body mass index decrease in massive weight loss patients: A retrospective cohort study | 27.3 | 0 | 2 |
| The impact of pre- and post-operative weight loss and body mass index on prognosis in patients with oesophageal cancer | 27.3 | 0 | 2 |
| Veterans with PTSD report more weight loss barriers than Veterans with no mental health disorders | 27.3 | 0 | 2 |
| Transformative Lifestyle Change: key to sustainable weight loss among women in a post‐partum diet and exercise intervention | 27.3 | 0 | 2 |
| EFFECTS OF OATS ON LIPID PROFILE, INSULIN RESISTANCE AND WEIGHT LOSS | 27.3 | 0 | 2 |
| Body mass index, adipokines and insulin resistance in asthmatic children and adolescents | 27.3 | 0 | 2 |
| Early treatment response as a predictor of ongoing weight loss in obesity treatment. | 27.3 | 0 | 2 |
| A Larger Body Mass Index is Associated with Increased Atherogenic Dyslipidemia, Insulin Resistance, and Low-Grade Inflammation in Individuals with Metabolic Syndrome | 27.3 | 0 | 2 |
| Dual Intragastric Balloon: Single Ambulatory Center Spanish Experience with 60 Patients in Endoscopic Weight Loss Management | 27.3 | 0 | 2 |
| Impact of food craving and calorie intake on body mass index (BMI) changes during an 18-month behavioral weight loss trial | 27.3 | 0 | 2 |
| The Symptoms of Gastroesophageal Reflux Disease Correlate with High Body Mass Index, the Aspartate Aminotransferase/Alanine Aminotransferase Ratio and Insulin Resistance in Japanese Patients with Non-alcoholic Fatty Liver Disease | 27.3 | 0 | 2 |
| Sedentary behavior, body mass index, and weight loss maintenance among African American women | 27.3 | 0 | 2 |
| The role of physicians in promoting weight loss | 27.3 | 0 | 2 |
| Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice | 27.3 | 0 | 2 |
| Difference in weight loss based on ethnicity, age and comorbidity status in a publicly funded adult weight management centre: 1‐year results | 27.3 | 0 | 2 |
| Meal replacements as a weight loss tool in a population with severe mental illness | 27.3 | 0 | 2 |
| Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women | 27.3 | 0 | 2 |
| Study of phendimetrazine bitartrate as an appetite suppressant in relation to dosage, weight loss and side effects | 27.3 | 0 | 2 |
| Metabolic health across the body mass index spectrum in HIV-Infected and HIV-Uninfected Men. | 27.3 | 0 | 2 |
| Change in body mass index and insulin resistance after 1-year treatment with gonadotropin-releasing hormone agonists in girls with central precocious puberty | 27.3 | 0 | 2 |
| Body mass index and waist circumference are better predictors of insulin resistance than total body fat percentage in middle-aged and elderly Taiwanese | 27.3 | 0 | 2 |
| Overadjustment in Regression Analyses: Considerations When Evaluating Relationships Between Body Mass Index, Muscle Strength, and Body Size | 27.3 | 0 | 2 |
| “That's who I am: A fat person in a thin body”: Weight loss, negative self-evaluation, and mitigating strategies following weight loss surgery | 27.3 | 0 | 2 |
| Diet Quality of Breast Cancer Survivors after a Six-Month Weight Management Intervention: Improvements and Association with Weight Loss | 27.3 | 0 | 2 |
| Effects of a community-based weight loss program, jointly established by local government and university faculty, on weight loss and metabolic syndrome components: the Sodegaura Weight Management Study | 27.3 | 0 | 2 |
| Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss | 27.3 | 0 | 2 |
| Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance | 27.3 | 0 | 2 |
| GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet. | 27.3 | 0 | 2 |
| High- or low-carbohydrate diets: which is better for weight loss, insulin resistance, and fatty livers? | 27.3 | 0 | 2 |
| Effects of C358A missense polymorphism of the degrading enzyme fatty acid amide hydrolase on weight loss, adipocytokines, and insulin resistance after 2 hypocaloric diets. | 27.3 | 0 | 2 |
| High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance. | 27.3 | 0 | 2 |
| Former small for gestational age (SGA) status is associated to changes of insulin resistance in obese children during weight loss | 27.3 | 0 | 2 |
| Cardiovascular risk profile and insulin resistance according body mass index, waist circumference and hypertriglyceridemic waist in adult subjects | 27.3 | 0 | 2 |
| Leptin concentrations in patients with polycystic ovary syndrome before and after met-formin treatment depending on insulin resistance, body mass index and androgen con-centrations--introductory report | 27.3 | 0 | 2 |
| Association of body mass index and insulin resistance with metabolic syndrome in Brazilian children. | 27.3 | 0 | 2 |
| Improvement of left ventricular function by lifestyle intervention in obesity: contributions of weight loss and reduced insulin resistance | 27.3 | 0 | 2 |
| Improvement in insulin resistance and reduction in plasma inflammatory adipokines after weight loss in obese dogs. | 27.3 | 0 | 2 |
| Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Achieving patient satisfaction in abdominally based free flap breast reconstruction: correlation with body mass index subgroups and weight loss | 27.3 | 0 | 2 |
| Gender differences in body mass index and weight loss strategies among African Americans | 27.3 | 0 | 2 |
| Insulin resistance precedes weight loss in adults without diabetes : the Rancho Bernardo Study | 27.3 | 0 | 2 |
| Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women | 27.3 | 0 | 2 |
| Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity | 27.3 | 0 | 2 |
| Insulin resistance in patients with cancer: relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure | 27.3 | 0 | 2 |
| A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss | 27.3 | 0 | 2 |
| Association between Blood Pressure and Insulin Resistance in Obese Females during Weight Loss and Weight Rebound Phenomenon | 27.3 | 0 | 2 |
| Body mass index status is effective in identifying metabolic syndrome components and insulin resistance in Pacific Island teenagers living in New Zealand | 27.3 | 0 | 2 |
| Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population | 27.3 | 0 | 2 |
| Body Mass Index and Weight Loss in Overweight and Obese Korean Women: The Mediating Role of Body Weight Perception | 27.3 | 0 | 2 |
| Leptin levels are appropriate for body mass index in older men who experience involuntary weight loss | 27.3 | 0 | 2 |
| Weight loss after Swedish Adjustable Gastric Banding: relationships to insulin resistance and metabolic syndrome | 27.3 | 0 | 2 |
| Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content | 27.3 | 0 | 2 |
| Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients | 27.3 | 0 | 2 |
| Weight loss-induced plasticity of glucose transport and phosphorylation in the insulin resistance of obesity and type 2 diabetes | 27.3 | 0 | 2 |
| Body mass index (BMI) and weight loss in patients with congenital heart disease. | 27.3 | 0 | 2 |
| The effect of preoperative weight loss and body mass index on postoperative outcome in patients with esophagogastric carcinoma | 27.3 | 0 | 2 |
| Impacts of Efficacy and Exemplification in an Online Message About Weight Loss on Weight Management Self-Efficacy, Satisfaction, and Personal Importance | 27.3 | 0 | 2 |
| Meal replacement based on Human Ration modulates metabolic risk factors during body weight loss: a randomized controlled trial | 27.3 | 0 | 2 |
| Long-Term Sympathoinhibitory Effects of Surgically Induced Weight Loss in Severe Obese Patients | 27.3 | 0 | 2 |
| Preoperative unintended weight loss and low body mass index in relation to complications and length of stay after cardiac surgery | 27.3 | 0 | 2 |
| Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes | 27.3 | 0 | 2 |
| Anthropometric parameters in evaluating malnutrition in oncological patients; utility of body mass index and percentage of weight loss | 27.3 | 0 | 2 |
| Body mass index is the most important determining factor for the degree of insulin resistance in non-obese type 2 diabetic patients in Korea | 27.3 | 0 | 2 |
| Weight loss and body mass index in relation to aspiration in patients treated for head and neck cancer: a long-term follow-up. | 27.3 | 0 | 2 |
| Study on the metabolic health risks of body mass index and waist circumference | 27.3 | 0 | 2 |
| Predictors of clinically significant weight loss and participant retention in an insurance-sponsored community-based weight management program | 27.3 | 0 | 2 |
| Cortisol and its relation to insulin resistance before and after weight loss in obese children | 27.3 | 0 | 2 |
| Effects of weight loss in obese subjects with normal fasting plasma glucose or impaired glucose tolerance on insulin release and insulin resistance according to a minimal model analysis | 27.3 | 0 | 2 |
| Analysis of the relationship between body mass index, insulin resistance, and beta-cell function: a cross-sectional study using the minimal model. | 27.3 | 0 | 2 |
| Digestive neoplasia, low body mass index and weight loss as indicators of the length of hospital stay in patients with neoplasia | 27.3 | 0 | 2 |
| Differential effect of weight loss on insulin resistance in surgically treated obese patients. | 27.3 | 0 | 2 |
| Desire for body contouring surgery after bariatric surgery: do body mass index and weight loss matter? | 27.3 | 0 | 2 |
| Patient predictors of weight loss following a behavioral weight management intervention among US Veterans with severe obesity. | 27.3 | 0 | 2 |
| Weight loss after participation in a national VA weight management program among veterans with or without PTSD. | 27.3 | 0 | 2 |
| Weight loss in obese prepubertal children: the influence of insulin resistance | 27.3 | 0 | 2 |
| Algorithm for weight loss after gastric bypass surgery considering body mass index, gender, and age from the Bariatric Outcome Longitudinal Database (BOLD) | 27.3 | 0 | 2 |
| Genetic variation in the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) and their influence on weight loss and insulin resistance under a high monounsaturated fat hypocaloric diet. | 27.3 | 0 | 2 |
| A polyphenol-rich cranberry extract reverses insulin resistance and hepatic steatosis independently of body weight loss | 27.3 | 0 | 2 |
| Does adherence to a motivational counseling program impact weight loss? | 27.3 | 0 | 2 |
| Insulin Resistance can be Easily Estimated by Body Mass Index and Waist Circumference in a General Japanese Population | 27.3 | 0 | 2 |
| Alcohol consumption is associated with decreased insulin resistance independent of body mass index in Japanese community-dwelling men. | 27.3 | 0 | 2 |
| The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans | 27.3 | 0 | 2 |
| Body mass index and waist circumference associate to a comparable degree with insulin resistance and related metabolic abnormalities in South Asian women and men | 27.3 | 0 | 2 |
| Metformin in combination with structured lifestyle intervention improved body mass index in obese adolescents, but did not improve insulin resistance | 27.3 | 0 | 2 |
| Influence of Trp64Arg polymorphism of beta 3-adrenoreceptor gene on insulin resistance, adipocytokines and weight loss secondary to two hypocaloric diets | 27.3 | 0 | 2 |
| Effects of diet cycling on weight loss, fat loss and resting energy expenditure in women | 27.3 | 0 | 2 |
| Homeostasis model assessment of insulin resistance*body mass index interactions at ages 9 to 10 years predict metabolic syndrome risk factor aggregate score at ages 18 to 19 years: a 10-year prospective study of black and white girls | 27.3 | 0 | 2 |
| Reduced arterial stiffness after weight loss in obese type 2 diabetes and impaired glucose tolerance: the role of immune cell activation and insulin resistance | 27.3 | 0 | 2 |
| Seasonal weight loss and metabolic adaptation in rural Beninese women: the relationship with body mass index | 27.3 | 0 | 2 |
| Influence of G308A promoter variant of tumor necrosis factor-alpha gene on insulin resistance and weight loss secondary to two hypocaloric diets: a randomized clinical trial. | 27.3 | 0 | 2 |
| Metabolic syndrome and insulin resistance significantly correlate with body mass index | 27.3 | 0 | 2 |
| Weight loss on low‐fat vs. low‐carbohydrate diets by insulin resistance status among overweight adults and adults with obesity: A randomized pilot trial | 27.3 | 0 | 2 |
| Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance | 27.3 | 0 | 2 |
| Understanding the relationship between weight loss, emotional well-being and health-related quality of life in patients attending a specialist obesity weight management service | 27.3 | 0 | 2 |
| Elevated concentrations of liver enzymes and ferritin identify a new phenotype of insulin resistance: effect of weight loss after gastric banding | 27.3 | 0 | 2 |
| Maintenance of weight loss in patients with body mass index >60 kg/m2: importance of length of small bowel bypassed | 27.3 | 0 | 2 |
| Relation of body mass index and insulin resistance to cardiovascular risk factors, inflammatory factors, and oxidative stress during adolescence | 27.3 | 0 | 2 |
| Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. | 27.3 | 0 | 2 |
| Efficacy of healthy weight loss program in obesity treatment: Croatian experience | 27.3 | 0 | 2 |
| Free fatty acids, insulin resistance, and corrected qt intervals in morbid obesity: effect of weight loss during 6 months with differing dietary interventions | 27.3 | 0 | 2 |
| Dietary restriction and Sirtuin 1 in metabolic health: connections and divergences | 27.3 | 0 | 2 |
| Long-term effects of popular dietary approaches on weight loss and features of insulin resistance | 27.3 | 0 | 2 |
| Effect of weight loss on blood pressure, arterial compliance, and insulin resistance in normotensive obese subjects | 27.3 | 0 | 2 |
| Impact of age, body mass index, insulin resistance and proteinuria on the kidney function in obese patients with Type 2 diabetes and renal insufficiency. | 27.3 | 0 | 2 |
| Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes | 27.3 | 0 | 2 |
| Relation of birth weight, body mass index, and change in size from birth to adulthood to insulin resistance in a female twin cohort | 27.3 | 0 | 2 |
| Left ventricular assist device in patients with body mass index greater than 30 as bridge to weight loss and heart transplant candidacy. | 27.3 | 0 | 2 |
| Fat loss depends on energy deficit only, independently of the method for weight loss | 27.3 | 0 | 2 |
| Changes in serum leptin and beta endorphin levels with weight loss by electroacupuncture and diet restriction in obesity treatment | 27.3 | 0 | 2 |
| Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels | 27.3 | 0 | 2 |
| A structured weight management programme can achieve improved functional ability and significant weight loss in obese patients with chronic kidney disease | 27.3 | 0 | 2 |
| Age- and body mass index-dependent relationship between correction of iron deficiency anemia and insulin resistance in non-diabetic premenopausal women | 27.3 | 0 | 2 |
| Plasma obestatin concentrations are negatively correlated with body mass index, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa | 27.3 | 0 | 2 |
| Fasting Ghrelin Levels Are Decreased in Obese Subjects and Are Significantly Related With Insulin Resistance and Body Mass Index. | 27.3 | 0 | 2 |
| Late-Life Body Mass Index, Rapid Weight Loss, Apolipoprotein E ε4 and the Risk of Cognitive Decline and Incident Dementia. | 27.3 | 0 | 2 |
| Erratum to: Evaluation of a multiprofessional, nonsurgical obesity treatment program: which parameters indicated life style changes and weight loss? | 27.3 | 0 | 2 |
| Weight loss and frequency of body-weight self-monitoring in an online commercial weight management program with and without a cellular-connected 'smart' scale: a randomized pilot study | 27.3 | 0 | 2 |
| Characterizing the Pattern of Weight Loss and Regain in Adults Enrolled in a 12-Week Internet-Based Weight Management Program | 27.3 | 0 | 2 |
| The effect of impaired glucose metabolism on weight loss in multidisciplinary childhood obesity treatment. | 27.3 | 0 | 2 |
| Impact of body mass index, metabolic health and weight change on incident diabetes in a Korean population | 27.3 | 0 | 2 |
| Role of rs1501299 variant in the adiponectin gene on total adiponectin levels, insulin resistance and weight loss after a Mediterranean hypocaloric diet. | 27.3 | 0 | 2 |
| Maintenance of weight loss after obesity treatment: is continuous support necessary? | 27.3 | 0 | 2 |
| The effects of multi-component weight management interventions on weight loss in adults with intellectual disabilities and obesity: A systematic review and meta-analysis of randomised controlled trials | 27.3 | 0 | 2 |
| Surgery type and psychosocial factors contribute to poorer weight loss outcomes in persons with a body mass index greater than 60 kg/m2 | 27.3 | 0 | 2 |
| Preoperative weight loss with glucagon-like peptide-1 receptor agonist treatment predicts greater weight loss achieved by the combination of medical weight management and bariatric surgery in patients with type 2 diabetes: A longitudinal analysis. | 27.3 | 0 | 2 |
| Following weight loss in massively obese patients correction of the insulin resistance of fat metabolism is delayed relative to the improvement in carbohydrate metabolism | 27.3 | 0 | 2 |
| Weight management and weight loss strategies of professional jockeys | 27.3 | 0 | 2 |
| Body mass index, weight loss and energy intake of old Danish nursing home residents and home-care clients | 27.3 | 0 | 2 |
| Influence of previous body mass index and sex on regional fat changes in a weight loss intervention | 27.3 | 0 | 2 |
| Effects of C358A polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase (FAAH) on weight loss, adipocytokines levels, and insulin resistance after a high polyunsaturated fat diet in obese patients | 27.3 | 0 | 2 |
| Malnutrition in older patients with cancer: Appraisal of the Mini Nutritional Assessment, weight loss, and body mass index | 27.3 | 0 | 2 |
| Comparison of Yukon Women by Weight Loss Effort and Body Mass Index: Self-reported Nutrition and Exercise Practices and Beliefs and Self-rated Health. | 27.3 | 0 | 2 |
| Greater history of weight-related stigmatizing experience is associated with greater weight loss in obesity treatment | 27.3 | 0 | 2 |
| Second trimester insulin resistance, early pregnancy body mass index and gestational weight gain | 27.3 | 0 | 2 |
| Medical Devices; Gastroenterology-Urology Devices; Classification of the Oral Removable Palatal Space Occupying Device for Weight Management and/or Weight Loss. Final order | 27.3 | 0 | 2 |
| Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss | 27.3 | 0 | 2 |
| Insulin resistance and inflammation predict kinetic body weight changes in response to dietary weight loss and maintenance in overweight and obese subjects by using a Bayesian network approach | 27.3 | 0 | 2 |
| Low-calorie diet induced weight loss may alter regulatory hormones and contribute to rebound visceral adiposity in obese persons with a family history of type-2 diabetes | 27.3 | 0 | 2 |
| Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: relationship with metabolic outcomes | 27.3 | 0 | 2 |
| Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass-induced weight loss | 27.3 | 0 | 2 |
| Comment on: Algorithm for weight loss after gastric bypass surgery considering body mass index, gender, and age from the bariatric outcome longitudinal database | 27.3 | 0 | 2 |
| Comparison of simple indices for measuring insulin resistance that integrates adipokines in non-diabetic obese postmenopausal women before and after weight loss: A MONET study | 27.3 | 0 | 2 |
| The rs10401670 variant in resistin gene improved insulin resistance response and metabolic parameters secondaries to weight loss after a hypocaloric diet | 27.3 | 0 | 2 |
| Gender differences in the associations among body mass index, weight loss, exercise, and drinking among college students | 27.3 | 0 | 2 |
| Childhood obesity treatment: telephone coaching is as good as usual care in maintaining weight loss - a randomized controlled trial. | 27.3 | 0 | 2 |
| Effect of weight loss and antiandrogenic therapy on sex hormone blood levels and insulin resistance in obese patients with polycystic ovaries | 27.3 | 0 | 2 |
| The effect of weight loss surgery and body mass index on wound complications after abdominal contouring operations | 27.3 | 0 | 2 |
| Psychological disorder, symptom severity and weight loss in inpatient adolescent obesity treatment | 27.3 | 0 | 2 |
| Relationships between changes in leptin and insulin resistance levels in obese individuals following weight loss. | 27.3 | 0 | 2 |
| Periparturient dairy cows do not exhibit hepatic insulin resistance, yet adipose-specific insulin resistance occurs in cows prone to high weight loss | 27.3 | 0 | 2 |
| Set-up errors in patients undergoing image guided radiation treatment. Relationship to body mass index and weight loss. | 27.3 | 0 | 2 |
| Associations of leptin, insulin resistance and thyroid function with long-term weight loss in dieting obese men. | 27.3 | 0 | 2 |
| Can body mass index predict percent body fat and changes in percent body fat with weight loss in bariatric surgery patients? | 27.3 | 0 | 2 |
| Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index | 27.3 | 0 | 2 |
| Is There an Optimal Diet for Weight Management and Metabolic Health? | 27.3 | 0 | 2 |
| Task-based weight management programme delivered in primary care promotes better long-term weight loss among women from lower socioeconomic groups than usual practice. | 27.3 | 0 | 2 |
| Diminished insulin resistance with weight loss in severely overweight youth | 27.3 | 0 | 2 |
| One-year effectiveness of two hypocaloric diets with different protein/carbohydrate ratios in weight loss and insulin resistance | 27.3 | 0 | 2 |
| The rs1862513 Variant in Resistin Gene-Modified Insulin Resistance and Insulin Levels after Weight Loss Secondary to Hypocaloric Diet | 27.3 | 0 | 2 |
| Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss | 27.3 | 0 | 2 |
| Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss | 27.3 | 0 | 2 |
| Influence of the Trp64Arg polymorphism in the beta 3 adrenoreceptor gene on insulin resistance, adipocytokine response, and weight loss secondary to lifestyle modification in obese patients | 27.3 | 0 | 2 |
| Impact of weight loss with or without exercise on abdominal fat and insulin resistance in obese individuals: a randomised clinical trial | 27.3 | 0 | 2 |
| Effects of diet composition on weight loss, metabolic factors and biomarkers in a 1-year weight loss intervention in obese women examined by baseline insulin resistance status | 27.3 | 0 | 2 |
| Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss | 27.3 | 0 | 2 |
| Insulin resistance predicts the effectiveness of different glycemic index diets on weight loss in non-obese women. | 27.3 | 0 | 2 |
| Are smaller weight losses or more achievable weight loss goals better in the long term for obese patients? | 27.3 | 0 | 2 |
| Do more specific plans help you lose weight? Examining the relationship between plan specificity, weight loss goals, and plan content in the context of a weight management programme. | 27.3 | 0 | 2 |
| The impact of rapid weight loss (4%) on leptin, adiponectin, and insulin resistance in elite adult free style wrestlers | 27.3 | 0 | 2 |
| Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss | 27.3 | 0 | 2 |
| Multivitamin use in relation to self-reported body mass index and weight loss attempts. | 27.3 | 0 | 2 |
| Effects of Trp64Arg Mutation in the β3-Adrenergic Receptor Gene on Weight Loss, Body Fat Distribution, Glycemic Control, and Insulin Resistance in Obese Type 2 Diabetic Patients | 27.3 | 0 | 2 |
| Association of Waist Circumference and Body Fat Weight with Insulin Resistance in Male Subjects with Normal Body Mass Index and Normal Glucose Tolerance | 27.3 | 0 | 2 |
| Physical activity affects weight loss and weight management | 27.3 | 0 | 2 |
| Use of a weight loss index for evaluating weight management in adults | 27.3 | 0 | 2 |
| Self-efficacy, attendance, and weight loss in obesity treatment. | 27.3 | 0 | 2 |
| Obesity susceptibility loci on body mass index and weight loss in Spanish adolescents after a lifestyle intervention. | 27.3 | 0 | 2 |
| Effect of weight loss due to lifestyle intervention on subclinical cardiovascular dysfunction in obesity (body mass index >30 kg/m2). | 27.3 | 0 | 2 |
| Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Comment on “A Peptidomimetic Targeting White Fat Causes Weight Loss and Improved Insulin Resistance in Obese Monkeys” | 27.3 | 0 | 2 |
| Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women | 27.3 | 0 | 2 |
| What is a reasonable weight loss? Patients' expectations and evaluations of obesity treatment outcomes | 27.3 | 0 | 2 |
| Weight loss strategies for obese adults: personalized weight management program vs. standard care | 27.3 | 0 | 2 |
| Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass | 27.3 | 0 | 2 |
| Adjunctive Use of Appetite Suppressant Medications for Improved Weight Management in Bariatric Surgical Patients | 27.3 | 0 | 2 |
| Attrition and weight loss outcomes for patients with complex obesity, anxiety and depression attending a weight management programme with targeted psychological treatment | 27.3 | 0 | 2 |
| Weight management issues and strategies for people with high cardiovascular risk undertaking an Australian weight loss program: A focus group study | 27.3 | 0 | 2 |
| HDL-sphingomyelin reduction after weight loss by an energy-restricted diet is associated with the improvement of lipid profile, blood pressure, and decrease of insulin resistance in overweight/obese patients | 27.3 | 0 | 2 |
| Supplementation of n3 Long-chain Polyunsaturated Fatty Acid Synergistically Decreases Insulin Resistance with Weight Loss of Obese Prepubertal and Pubertal Children | 27.3 | 0 | 2 |
| Gender differences in body mass index, body weight perception and weight loss strategies among undergraduates in Universiti Malaysia Sarawak | 27.3 | 0 | 2 |
| The association of SNP276G>T at adiponectin gene with circulating adiponectin and insulin resistance in response to mild weight loss | 27.3 | 0 | 2 |
| Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals | 27.3 | 0 | 2 |
| Do feeding practices of obese dogs, before weight loss, affect the success of weight management? | 27.3 | 0 | 2 |
| Patient characteristics as predictors of weight loss after an obesity treatment for children | 27.3 | 0 | 2 |
| Relationship between sex of parent and child on weight loss and maintenance in a family-based obesity treatment program | 27.3 | 0 | 2 |
| Metformin and placebo therapy in adjunct with lifestyle intervention both improve weight loss and insulin resistance in obese adolescents | 27.3 | 0 | 2 |
| A preliminary investigation into whether early intervention can improve weight loss among those initially non-responsive to an internet-based behavioral program | 27.3 | 0 | 2 |
| Psycho-markers of weight loss. The roles of TFEQ Disinhibition and Restraint in exercise-induced weight management | 27.3 | 0 | 2 |
| Implantable gastric stimulation to achieve weight loss in patients with a low body mass index: early clinical trial results | 27.3 | 0 | 2 |
| Weight loss and reduced body mass index: a critical issue in children with multiorgan chronic graft-versus-host disease | 27.3 | 0 | 2 |
| Work stress, weight gain and weight loss: evidence for bidirectional effects of job strain on body mass index in the Whitehall II study | 27.3 | 0 | 2 |
| Factors associated with low body mass index and weight loss in nursing home residents | 27.3 | 0 | 2 |
| Altered Insulin Resistance Is Associated with Increased Dietary Weight Loss in Obese Children | 27.3 | 0 | 2 |
| Kamp K'aana, a 2‐Week Residential Weight Management Summer Camp, Shows Long‐Term Improvement in Body Mass Index z Scores | 27.3 | 0 | 2 |
| Weight loss and improved gross motor coordination in children as a result of multidisciplinary residential obesity treatment | 27.3 | 0 | 2 |
| ROLE OF RS9939609 FTO GENE VARIANT IN WEIGHT LOSS, INSULIN RESISTANCE AND METABOLIC PARAMETERS AFTER A HIGH MONOUNSATURATED VS A HIGH POLYUNSATURATED FAT HYPOCALORIC DIETS. | 27.3 | 0 | 2 |
| The Effect of Bariatric Surgery Type on Lipid Profile: An Age, Sex, Body Mass Index and Excess Weight Loss Matched Study | 27.3 | 0 | 2 |
| Weight loss increased serum adiponectin but decreased lipid levels in obese subjects whose body mass index was lower than 30 kg/m2 | 27.3 | 0 | 2 |
| A comparison of skinfold thickness, body mass index, bioelectrical impedance analysis and dual-energy X-ray absorptiometry in assessing body composition in obese subjects before and after weight loss | 27.3 | 0 | 2 |
| Circulating soluble leptin receptor, leptin, and insulin resistance before and after weight loss in obese children | 27.3 | 0 | 2 |
| Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet | 27.3 | 0 | 2 |
| Participation as a leader in immersion weight loss treatment may benefit, not harm, young adult staff members | 27.3 | 0 | 2 |
| Exercise-Induced Weight Loss Is More Effective Than Dieting for Improving Adipokine Profile, Insulin Resistance, and Inflammation in Obese Men | 27.3 | 0 | 2 |
| The Italian Group for LAP-BAND: predictive value of initial body mass index for weight loss after 5 years of follow-up. | 27.3 | 0 | 2 |
| Prevalence of body mass index and body weight cut-off points for in vitro fertilization treatment at U.S. clinics and current clinic weight loss strategy recommendations | 27.3 | 0 | 2 |
| Determinants of neonatal weight loss in term-infants: specific association with pre-pregnancy maternal body mass index and infant feeding mode | 27.3 | 0 | 2 |
| Relative Outcome Measures for Bariatric Surgery. Evidence Against Excess Weight Loss and Excess Body Mass Index Loss from a Series of Laparoscopic Roux-en-Y Gastric Bypass Patients | 27.3 | 0 | 2 |
| Rorschach personality predictors of weight loss with behavior modification in obesity treatment | 27.3 | 0 | 2 |
| Modest weight loss through a 12-week weight management program with behavioral modification seems to attenuate inflammatory responses in young obese Koreans. | 27.3 | 0 | 2 |
| Impact of body mass index and weight loss on cancer-specific and overall survival in patients with surgically resected renal cell carcinoma | 27.3 | 0 | 2 |
| A clinical trial of an appetite suppressant in refractory obesity (with a note on assessment of weight loss) | 27.3 | 0 | 2 |
| Weight Loss Reporting: Predicted Body Mass Index After Bariatric Surgery | 27.3 | 0 | 2 |
| The effect of rate of weight loss on long-term weight management: a randomised controlled trial. | 27.3 | 0 | 2 |
| The Use of Technology for Delivering a Weight Loss Program for Adolescents with Intellectual and Developmental Disabilities | 27.3 | 0 | 2 |
| Effects of equal weight loss with orlistat and placebo on body fat and serum fatty acid composition and insulin resistance in obese women | 27.3 | 0 | 2 |
| Change in body image and psychological well-being during behavioral obesity treatment: Associations with weight loss and maintenance. | 27.3 | 0 | 2 |
| Factors predictive of drop‐out and weight loss success in weight management of obese patients | 27.3 | 0 | 2 |
| Gender differences in weight loss; evidence from a NHS weight management service. | 27.3 | 0 | 2 |
| Body Mass Index Self‐Perception and Weight Management Behaviors During Late Adolescence | 27.3 | 0 | 2 |
| Initial weight loss is the best predictor for success in obesity treatment and sociodemographic liabilities increase risk for drop-out | 27.3 | 0 | 2 |
| Psychosocial factors and perspectives on weight gain and barriers to weight loss among adolescents enrolled in obesity treatment | 27.3 | 0 | 2 |
| Inflammatory status is different in relationship to insulin resistance in severely obese people and changes after bariatric surgery or diet-induced weight loss | 27.3 | 0 | 2 |
| Long-Term Weight Loss Effects of a Behavioral Weight Management Program: Does the Community Food Environment Matter? | 27.3 | 0 | 2 |
| The influence of body mass index and weight loss on outcome of elderly patients undergoing lung cancer resection | 27.3 | 0 | 2 |
| Effects of fruit consumption on body mass index and weight loss in a sample of overweight and obese dieters enrolled in a weight-loss intervention trial | 27.3 | 0 | 2 |
| Low-grade inflammation in overweight and obese adults is affected by weight loss program | 27.3 | 0 | 2 |
| A comparison of mid upper arm circumference, body mass index and weight loss as indices of undernutrition in acutely hospitalized patients | 27.3 | 0 | 2 |
| Endogenous thrombin potential in polycystic ovary syndrome: the association to body mass index, insulin resistance, and inflammation. | 27.3 | 0 | 2 |
| Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance. | 27.3 | 0 | 2 |
| The brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophrenia | 27.3 | 0 | 2 |
| Chylomicron-Derived Fatty Acid Spillover in Adipose Tissue: A Signature of Metabolic Health? | 27.3 | 0 | 2 |
| Heterogenous origins of hyperandrogenism in the polycystic ovary syndrome in relation to body mass index and insulin resistance | 27.3 | 0 | 2 |
| HNF1A variant, energy-reduced diets and insulin resistance improvement during weight loss: the POUNDS Lost and DIRECT trials | 27.3 | 0 | 2 |
| Amino acid profiles of young adults differ by sex, body mass index and insulin resistance. | 27.3 | 0 | 2 |
| Influence of insulin resistance and body mass index at age 13 on systolic blood pressure, triglycerides, and high-density lipoprotein cholesterol at age 19. | 27.3 | 0 | 2 |
| Body mass index and the desire of weight loss in a group of young women | 27.3 | 0 | 2 |
| Insulin Resistance and Lipid Accumulation Product in Corelation to Body Mass Index in Women with Polycystic Ovary Syndrome | 27.3 | 0 | 2 |
| Body mass index, a major confounder to insulin resistance association with unprovoked venous thromboembolism. Results from the EDITH case-control study | 27.3 | 0 | 2 |
| Impact of a behaviorally-based weight loss intervention on parameters of insulin resistance in breast cancer survivors | 27.3 | 0 | 2 |
| Insulin Resistance Improves More in Women than In Men in Association with a Weight Loss Intervention | 27.3 | 0 | 2 |
| Do Differences in Waist Circumference Modify the Relationships Among Body Mass Index, Insulin Resistance, and Related Cardiometabolic Risk Factors in Apparently Healthy Women? | 27.3 | 0 | 2 |
| Better association of waist circumference with insulin resistance and some cardiovascular risk factors than body mass index | 27.3 | 0 | 2 |
| Dyslipidemia in relation to body mass index and insulin resistance in Chinese women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Phenotypic expression, body mass index and insulin resistance in relation to LH levels in women with polycystic ovary syndrome | 27.3 | 0 | 2 |
| Effect of regional fat loss assessed by DXA on insulin resistance and dyslipidaemia in obese women | 27.3 | 0 | 2 |
| Endothelial function in young women with polycystic ovary syndrome (PCOS): Implications of body mass index (BMI) and insulin resistance. | 27.3 | 0 | 2 |
| Insulin resistance, as expressed by HOMA-R, is strongly determined by waist circumference or body mass index among Japanese working men | 27.3 | 0 | 2 |
| Effect of body mass index on insulin resistance and lipids in prepubertal and postpubertal children: SCHOOL observations | 27.3 | 0 | 2 |
| Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol | 27.3 | 0 | 2 |
| Insulin resistance, body mass index, waist circumference are independent risk factor for high blood pressure | 27.3 | 0 | 2 |
| Serum leptin and leptin receptors in healthy prepubertal children: relations to insulin resistance and lipid parameters, body mass index (BMI), tumor necrosis factor alpha (TNF alpha), heart fatty acid binding protein (hFABP), and IgG anticardiolipi | 27.3 | 0 | 2 |
| Insulin resistance: the link between impaired glucose tolerance, body mass index and plasma lipids. | 27.3 | 0 | 2 |
| Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3-4 chronic kidney disease patients | 27.3 | 0 | 2 |
| Changes in Body Mass Index and Physical Activity Predict Changes in Vitality During a Weight Loss Trial in Breast Cancer Survivors | 27.3 | 0 | 2 |
| Mesenteric visceral lipectomy using tissue liquefaction technology reverses insulin resistance and causes weight loss in baboons. | 27.3 | 0 | 2 |
| The short-and long term effect of multidisciplinary obesity treatment on body mass index and mental health | 27.3 | 0 | 2 |
| Body mass index increase before 3 years-of-age augments the degree of insulin resistance corresponding to body mass index in adolescent girls. | 27.3 | 0 | 2 |
| Increase of body mass index (BMI) from 1.5 to 3 years of age augments the degree of insulin resistance corresponding to BMI at 12 years of age. | 27.3 | 0 | 2 |
| A descriptive study of facial acanthosis nigricans and its association with body mass index, waist circumference and insulin resistance using HOMA2 IR. | 27.3 | 0 | 2 |
| Insulin resistance and coronary artery disease: body mass index may have affected results | 27.3 | 0 | 2 |
| Increased body mass index increase and insulin resistance parameters in dyslipidemia. Risk and positive correlation in essential obesity | 27.3 | 0 | 2 |
| Body Mass, Total Body Fat Percentage, and Visceral Fat Level Predict Insulin Resistance Better Than Waist Circumference and Body Mass Index in Healthy Young Male Adults in Indonesia | 27.3 | 0 | 2 |
| Factors Associated with Visceral Fat Loss in Response to a Multifaceted Weight Loss Intervention | 27.3 | 0 | 2 |
| Long-term weight loss trajectories following participation in a randomised controlled trial of a weight management programme for men delivered through professional football clubs: a longitudinal cohort study and economic evaluation. | 27.3 | 0 | 2 |
| Long-term weight loss following a randomised controlled trial of a weight management programme for men delivered through professional football clubs: the Football Fans in Training follow-up study | 27.3 | 0 | 2 |
| Insulin Resistance Is Associated With Advanced Liver Fibrosis and High Body Mass Index in HIV/HCV-Coinfected Patients | 27.3 | 0 | 2 |
| Racial discrimination, body mass index, and insulin resistance: A longitudinal analysis | 27.3 | 0 | 2 |
| Assessing the feasibility of parent participation in a commercial weight loss program to improve child body mass index and weight-related health behaviors | 27.3 | 0 | 2 |
| Effect of the interaction between diet composition and the PPM1K genetic variant on insulin resistance and β cell function markers during weight loss: results from the Nutrient Gene Interactions in Human Obesity: implications for dietary guidelines | 27.3 | 0 | 2 |
| Insulin Resistance and Beat-to-Beat Cardiovascular Dynamics: A Constant Relationship Across Different Body Mass Index and Blood Pressure Categories | 27.3 | 0 | 2 |
| Erratum to: Improvement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months’ consumption of a combination of bioactive food ingredients in overweight subjects | 27.3 | 0 | 2 |
| Effect of Fat Loss on Arterial Elasticity in Obese Adolescents With Clinical Insulin Resistance: RESIST Study | 27.3 | 0 | 2 |
| Beyond weight loss: A qualitative exploration of participant expectations and strategies for measuring progress during a weight management program | 27.3 | 0 | 2 |
| "Last Supper" Predicts Greater Weight Loss Early in Obesity Treatment, but Not Enough to Offset Initial Gains | 27.3 | 0 | 2 |
| Effects of Infant Birthweight and Maternal Body Mass Index in Pregnancy on Components of the Insulin Resistance Syndrome in China | 27.3 | 0 | 2 |
| Development of a scalable weight loss intervention for low-income workers through adaptation of interactive obesity treatment approach (iOTA) | 27.3 | 0 | 2 |
| OP05 From Trial to Population: Effect of a Weight Management Intervention on body Mass Index When Scaled Up | 27.3 | 0 | 2 |
| High-Molecular-Weight Adiponectin Is Selectively Reduced in Women With Polycystic Ovary Syndrome Independent of Body Mass Index and Severity of Insulin Resistance | 27.3 | 0 | 2 |
| Exploring the use of adjusted body mass index thresholds based on equivalent insulin resistance for defining overweight and obesity in UK South Asian children | 27.3 | 0 | 2 |
| Weight management guides for pregnant women with a body mass index (BMI) ≥ 40kg/m2: A qualitative exploration of their use in maternity care | 27.3 | 0 | 2 |
| The Metabolic Effects of Different Weight Loss Diets | 27.3 | 0 | 2 |
| Phone Versus Clinical Approach to Weight Loss | 27.3 | 0 | 2 |
| Effect of a Unique Web-based Behaviour Change Program on Weight Loss and Cardiovascular Risk Factors | 27.3 | 0 | 2 |
| Intervention Study With Omega-3 Fatty Acids for Weight Loss and Insulin Resistance in Adolescents | 27.3 | 0 | 2 |
| Using the Electronic Health Record to Guide Management of Newborn Weight Loss | 27.3 | 0 | 2 |
| Energy Expenditure From ECAL Indirect Calorimeter in a Multicomponent Weight Management Service | 27.3 | 0 | 2 |
| Development and Pilot Testing of a Childhood Obesity Treatment Program | 27.3 | 0 | 2 |
| Progressive Weight Loss and Metabolic Health | 27.3 | 0 | 2 |
| CHRONOtype-adjusted DIET on Weight Loss | 27.3 | 0 | 2 |
| PACE CALL: Weight Loss Study for Childhood Leukemia Survivors | 27.3 | 0 | 2 |
| The Weight-Wise Weight Loss Translation Study | 27.3 | 0 | 2 |
| Weight Loss Diet Study: Low Carb vs Low Fat | 27.3 | 0 | 2 |
| A Study Evaluating the Effects of a High Viscosity Non-starch Polysaccharide (PolyGlycopleX® - PGX®) on Glycemic Control, Cardiometabolic Risk Factors and Weight Loss in Overweight and Obese Type II Diabetics | 27.3 | 0 | 2 |
| Lay Health Coaches for Weight Loss: Peers Versus Mentors | 27.3 | 0 | 2 |
| Effects of Re-Feeding Duration on Weight Maintenance After Weight Loss With Very-Low-Energy Diets (VLEDs) | 27.3 | 0 | 2 |
| Association of Variability in Body Mass Index and Metabolic Health With Cardiometabolic Disease Risk | 27.3 | 0 | 2 |
| Evaluation of a Primary Care Weight Management Program in Children Aged 2⁻5 years: Changes in Feeding Practices, Health Behaviors, and Body Mass Index | 27.3 | 0 | 2 |
| Is normal body mass index a good indicator of metabolic health in Azar cohort population? | 27.3 | 0 | 2 |
| Comparison of surgical versus diet-induced weight loss on appetite regulation and metabolic health outcomes | 27.3 | 0 | 2 |
| Effect of Integrated Behavioral Weight Loss Treatment and Problem-Solving Therapy on Body Mass Index and Depressive Symptoms Among Patients With Obesity and Depression: The RAINBOW Randomized Clinical Trial | 27.3 | 0 | 2 |
| Proteins Altered by Surgical Weight Loss Highlight Biomarkers of Insulin Resistance in the Community | 27.3 | 0 | 2 |
| The Effects of a Moderate Weight Loss on Insulin Resistance | 27.3 | 0 | 2 |
| Obesity Treatment Using an Internet-delivered Intervention Based on the Diabetes Prevention Program in Mexican Adults | 27.3 | 0 | 2 |
| Meal Patterning on Weight Loss With Changes to Body Comp, Muscle and Metabolic Health | 27.3 | 0 | 2 |
| Absolute Weight Loss, and Not Weight Loss Rate, Is Associated with Better Improvements in Metabolic Health | 27.3 | 0 | 2 |
| HealthyMe Online Weight Management Education/HealthyMe at Home | 27.3 | 0 | 2 |
| Age and Gender Corrected Body Mass Index | 27.3 | 0 | 2 |
| Cardiovascular Risk Markers in Polycystic Ovary Syndrome (PCOS) | 27.3 | 0 | 2 |
| STUDY: Effects of Potatoes in a Weight Loss Program | 27.3 | 0 | 2 |
| Think Health! A Personal Weight Management Program | 27.3 | 0 | 2 |
| GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children | 27.3 | 0 | 2 |
| Skeletal Muscle Lipid and Insulin Resistance: Effects of Physical Activity and Weight Loss | 27.3 | 0 | 2 |
| Gene Expression in Obesity and Insulin Resistance | 27.3 | 0 | 2 |
| Forearm Immobilization, Metabolic Health, and Muscle Loss | 27.3 | 0 | 2 |
| Pre-operative Exercise and Nutrition Therapy on Cardio-metabolic Health in Patients Undergoing Bariatric Surgery | 27.3 | 0 | 2 |
| Treatment Efforts Addressing Child Weight Management by Unifying Patients, Parents & Providers | 27.3 | 0 | 2 |
| 2-5 Intermittent Caloric Restriction for Weight Loss and Insulin Resistance in HIV-Infected Adults With Features of the Metabolic Syndrome | 27.3 | 0 | 2 |
| Maternal Hypertriglyceridaemia Study | 27.3 | 0 | 2 |
| The Effects of Including Almonds in a Weight Loss Trial | 27.3 | 0 | 2 |
| Correlation of Irisin and Adipokine Levels With Body Mass Index and Risk Factors for Metabolic Syndrome in Hispanic Children | 27.3 | 0 | 2 |
| Weight Loss Study-Mechanism Underlying the Improvement of Insulin Resistance in Response to Weight Loss | 27.3 | 0 | 2 |
| Effect of Increased Intake of Low Fat Dairy Products on Weight Loss and Insulin Resistance | 27.3 | 0 | 2 |
| Reducing Snack Variety in Weight Loss Treatment | 27.3 | 0 | 2 |
| W8Loss2Go: mHealth Weight Management Strategy | 27.3 | 0 | 2 |
| Internet Assisted Obesity Treatment | 27.3 | 0 | 2 |
| Impact of Protein Quantity Within the USDA Healthy Style Eating Pattern on Sleep | 27.3 | 0 | 2 |
| The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS | 27.3 | 0 | 2 |
| Effect of Weight Management Programs on Cardiometabolic Risk Profile in Overweight Women | 27.3 | 0 | 2 |
| The Heat Study: 2 Year Lifestyle Intervention in Overweight Women to Encourage Weight Management | 27.3 | 0 | 2 |
| NEW DAY: Nutrition, Exercise, Weight Loss, Diabetes And You | 27.3 | 0 | 2 |
| Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss | 27.3 | 0 | 2 |
| Efficacy of D-allulose on Weight and Fat Loss and Insulin Resistance in Non-diabetic Obese Subjects | 27.3 | 0 | 2 |
| Impact of Mobile Phone Texting Service to Support Weight Loss | 27.3 | 0 | 2 |
| Weight Loss Physical Disabilities | 27.3 | 0 | 2 |
| Connect for Health Pediatric Weight Management Program | 27.3 | 0 | 2 |
| Childhood Obesity Treatment - Telephone Coaching vc Usual Care | 27.3 | 0 | 2 |
| Smart Technology for Weight Loss and Metabolic Health | 27.3 | 0 | 2 |
| CARE Trial: Comparing Different Levels of Calorie Reduction for Weight Loss | 27.3 | 0 | 2 |
| Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults | 27.3 | 0 | 2 |
| Effects of tumor removal and body weight loss on insulin resistance in patients with cancer | 27.3 | 0 | 2 |
| Effects of tumor removal and body weight loss on insulin resistance: preliminary report | 27.3 | 0 | 2 |
| Assessment of nutritional risks among elderly hospitalized patients - which body mass index and degree of weight loss should be considered? | 27.3 | 0 | 2 |
| Physical exercise for preventing obesity, promoting weight loss and maintaining weight management | 27.3 | 0 | 2 |
| A disparity between conventional lipid and insulin resistance markers at body mass index levels greater than 34 kg/m(2) | 27.3 | 0 | 2 |
| Diet for the Maintenance of Weight Loss and Metabolic Health in Obese Postmenopausal Women | 27.3 | 0 | 2 |
| Engaging Patients in Weight Loss Tools | 27.3 | 0 | 2 |
| High-intensity Interval Training for Obese Individuals | 27.3 | 0 | 2 |
| Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents | 27.3 | 0 | 2 |
| Weight loss can be as simple as 10, 20, 30--Knoll launches blueprint for the use of sibutramine in weight management | 27.3 | 0 | 2 |
| Weight loss increases and fat loss decreases all-cause mortality rate: results from two independent cohort studies | 27.3 | 0 | 2 |
| Repeated amenorrhea after body weight loss. Efficacy of treatment of estrogen and gestagen depending on the body mass index | 27.3 | 0 | 2 |
| Relationship between polycystic ovaries, body mass index and insulin resistance | 27.3 | 0 | 2 |
| Comparison of the effect of orlistat vs orlistat plus metformin on weight loss and insulin resistance in obese women | 27.3 | 0 | 2 |
| Rate of change and instability in body mass index, insulin resistance, and lipid metabolism as predictors of atherosclerotic vascular disease | 27.3 | 0 | 2 |
| Influence of G308A polymorphism of tumor necrosis factor alpha gene on insulin resistance in obese patients after weight loss | 27.3 | 0 | 2 |
| CBT for obesity treatment in primary health care. Randomized trials show good weight loss 1,5 year following treatment | 27.3 | 0 | 2 |
| Determinants of age at natural menopause in the Isparta Menopause and Health Study: premenopausal body mass index gain rate and episodic weight loss | 27.3 | 0 | 2 |
| The effect of weight loss on serum concentration of interleukine-6 (IL-6) and insulin resistance | 27.3 | 0 | 2 |
| Even moderate weight loss can lower your heart risk. Research shows that strength training and aerobic exercise can help sedentary seniors decrease their risk for insulin resistance | 27.3 | 0 | 2 |
| Motivation, behavior change, and weight management. Motivation-enforced weight loss programs conducted via the Internet may be the silver bullet for the nation's obesity epidemic | 27.3 | 0 | 2 |
| Waist circumference is a better predictor than body mass index of insulin resistance in type 2 diabetes | 27.3 | 0 | 2 |
| Association of smoking status, insulin resistance, body mass index, and metabolic syndrome in workers: A 1-year follow-up study | 27.3 | 0 | 2 |
| METFORMIN-SUSTAINED WEIGHT LOSS AND REDUCED ANDROID FAT TISSUE AT 12 MONTHS IN EMPOWIR (ENHANCE THE METABOLIC PROFILE OF WOMEN WITH INSULIN RESISTANCE): A DOUBLE BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL OF NORMOGLYCEMIC WOMEN WITH MIDLIFE WEIGHT | 27.3 | 0 | 2 |
| Impact of Visceral Fat Measurements and a Weight Loss Support Web System on Visceral Fat Loss in a Workplace Setting: Insights from a JVALUE2 (Japanese Study of Visceral Adiposity and Lifestyle Information; Utilization and Evaluation) | 27.3 | 0 | 2 |
| Associations between fiber intake and Body Mass Index (BMI) among African-American women participating in a randomized weight loss and maintenance trial | 27.3 | 0 | 2 |
| Intensive weight management in primary care improved weight loss and remission of type 2 diabetes | 27.3 | 0 | 2 |
| Body mass index delineates ALS from FTD: implications for metabolic health | 27.3 | 0 | 2 |
| Prognostic Roles of Perioperative Body Mass Index and Weight Loss in the Long-Term Survival of Gastric Cancer Patients | 27.3 | 0 | 2 |
| Role of rs670 variant of APOA1 gene on lipid profile, insulin resistance and adipokine levels in obese subjects after weight loss with a dietary intervention | 27.3 | 0 | 2 |
| The Relationship between Circulating Acetate and Human Insulin Resistance before and after Weight Loss in the DiOGenes Study | 27.3 | 0 | 2 |
| DIAL now protocol: A randomized trial examining the provision of phone coaching to those with sub-optimal early weight loss during an Internet weight management program | 27.3 | 0 | 2 |
| A real-life multicenter study on body weight loss and body mass index in advanced Gastric Cancer patients treated with Ramucirumab-based second-line therapy | 27.3 | 0 | 2 |
| Prognostic value of preoperative weight loss-adjusted body mass index on survival after esophagectomy for esophageal squamous cell carcinoma | 27.3 | 0 | 2 |
| Body mass index ≥23 is a risk factor for insulin resistance and diabetes in Japanese people: A brief report | 27.3 | 0 | 2 |
| Weight loss and metabolic health effects from energy-restricted Mediterranean and Central-European diets in postmenopausal women: A randomized controlled trial | 27.3 | 0 | 2 |
| The Cambridge Intensive Weight Management Programme Appears to Promote Weight Loss and Reduce the Need for Bariatric Surgery in Obese Adults | 27.3 | 0 | 2 |
| Liraglutide, GLP-1 receptor agonist, for chronic weight loss | 27.3 | 0 | 2 |
| Effects of addictive-like eating behaviors on weight loss with behavioral obesity treatment | 27.3 | 0 | 2 |
| Higher serum level of CTRP15 in patients with coronary artery disease is associated with disease severity, body mass index and insulin resistance | 27.3 | 0 | 2 |
| Obesity Treatment: A Focus on Pharmacotherapy of Weight Management | 27.3 | 0 | 2 |
| Beyond weight loss: Impact of a weight management programme for mid-older Australians in private health insurance | 27.3 | 0 | 2 |
| Presence of CC Genotype for rs17773430 Could Affect the Percentage of Excess Weight Loss 1 Year After Bariatric Surgery: Tehran Obesity Treatment Study (TOTS) | 27.3 | 0 | 2 |
| Body Mass Index Change Between Referral to and Enrollment in Pediatric Weight Management | 27.3 | 0 | 2 |
| Long-Term Weight Loss and Metabolic Health in Adults Concerned With Maintaining or Losing Weight: Findings From NHANES | 27.3 | 0 | 2 |
| Author Correction: Weight loss and metabolic health effects from energy-restricted Mediterranean and Central-European diets in postmenopausal women: A randomized controlled trial | 27.3 | 0 | 2 |
| Protocol for a randomised controlled trial of the combined effects of the GLP-1 receptor agonist liraglutide and exercise on maintenance of weight loss and health after a very low-calorie diet | 27.3 | 0 | 2 |
| Child and parent reports of children's depressive symptoms in relation to children's weight loss response in family-based obesity treatment | 27.3 | 0 | 2 |
| Do stress eating or compulsive eating influence metabolic health in a mindfulness-based weight loss intervention? | 27.3 | 0 | 2 |
| Fractures in Adults After Weight Loss from Bariatric Surgery and Weight Management Programs for Obesity: Systematic Review and Meta-analysis | 27.3 | 0 | 2 |
| Weight loss in patients with type 2 diabetes receiving once-weekly dulaglutide plus insulin lispro or insulin glargine plus insulin lispro: A post-hoc analysis of the AWARD-4 study across baseline body mass index subgroups | 27.3 | 0 | 2 |
| The role of intermittent fasting and meal timing in weight management and metabolic health | 27.3 | 0 | 2 |
| Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study | 27.3 | 0 | 2 |
| Complex relationships between perfluorooctanoate, body mass index, insulin resistance and serum lipids in young girls | 27.3 | 0 | 2 |
| Weight loss and body mass index in advanced gastric cancer patients treated with second-line ramucirumab: a real-life multicentre study | 27.3 | 0 | 2 |
| Associations Between Romantic Relationship Factors and Body Mass Index Among Weight Loss Surgery Patients | 27.3 | 0 | 2 |
| Zinc supplementation improves body weight management, inflammatory biomarkers and insulin resistance in individuals with obesity: a randomized, placebo-controlled, double-blind trial | 27.3 | 0 | 2 |
| CORRIGENDUM FOR "Reductions in Insulin Resistance are Mediated Primarily via Weight Loss in Subjects With Type 2 Diabetes on Semaglutide" | 27.3 | 0 | 2 |
| Correlation of body mass index (BMI), anti-mullerian hormone (AMH), and insulin resistance among different polycystic ovary syndrome (PCOS) phenotypes - a cross-sectional study | 27.3 | 0 | 2 |
| Offering weight management support to pregnant women with high body mass index: A qualitative study with midwives | 27.3 | 0 | 2 |
| Effect of high dose vitamin D supplementation in combination with weight loss diet on Glucose homeostasis, insulin resistance and matrix metalloproteinases in obese subjects with vitamin D deficiency: a double blind placebo-controlled randomized cli | 27.3 | 0 | 2 |
| Knowledge-based Dietary Weight Management. | 27.3 | 0 | 2 |
| Efficacy of "Mentoring to Be Active" on Weight Loss, Body Mass Index, and Body Fat among Obese and Extremely Obese Youth in Rural Appalachia | 27.3 | 0 | 2 |
| Interplay between the Adaptive Immune System and Insulin Resistance in Weight Loss Induced by Bariatric Surgery | 27.3 | 0 | 2 |
| Letter to the Editor Concerning: Fractures in Adults After Weight Loss from Bariatric Surgery and Weight Management Programs for Obesity: Systematic Review and Meta-analysis | 27.3 | 0 | 2 |
| Short-term GLP-1 receptor agonist exenatide ameliorates intramyocellular lipid deposition without weight loss in ob/ob mice | 27.3 | 0 | 2 |
| Provider Counseling and Weight Loss Outcomes in a Primary Care-Based Digital Obesity Treatment | 27.3 | 0 | 2 |
| Limited Impact of Fetal Sex and Maternal Body Mass Index on Fetal and Maternal Insulin Resistance and Lipid Metabolism: Findings from the PEARs Study | 27.3 | 0 | 2 |
| Cardiorespiratory Fitness, Body Mass Index, and Markers of Insulin Resistance in Apparently Healthy Women and Men | 27.3 | 0 | 2 |
| Frequency of self-monitoring of blood glucose in relation to weight loss and A1C during intensive multidisciplinary weight management in patients with type 2 diabetes and obesity | 27.3 | 0 | 2 |
| In type 2 diabetes, a primary care-led weight management program increased weight loss and diabetes remission at 2 years | 27.3 | 0 | 2 |
| The Relationship Between Preoperative Kidney Function and Weight Loss After Bariatric Surgery in Patients with Estimated Glomerular Filtration Rate ≥ 30 mL/min: Tehran Obesity Treatment Study | 27.3 | 0 | 2 |
| Reductions in insulin resistance are mediated primarily via weight loss in subjects with type 2 diabetes on semaglutide | 27.3 | 0 | 2 |
| Behavioral and Psychological Strategies of Long-Term Weight Loss Maintainers in a Widely Available Weight Management Program | 27.3 | 0 | 2 |
| Two-Year Weight Loss but Not Body Mass Index Predicts Mortality and Disability in an Older Japanese Community-Dwelling Population | 27.3 | 0 | 2 |
| Integrated weight loss and cognitive behavioural therapy (CBT) for the treatment of recurrent binge eating and high body mass index: a randomized controlled trial | 27.3 | 0 | 2 |
| Weight loss variability with SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities | 27.3 | 0 | 2 |
| Pancreastatin inhibitor, PSTi8 ameliorates metabolic health by modulating AKT/GSK-3β and PKCλ/ζ/SREBP1c pathways in high fat diet induced insulin resistance in peri-/post-menopausal rats | 27.3 | 0 | 2 |
| Combined associations of body mass index and metabolic health status on medical and dental care days and costs in Japanese male employees: A 4-year follow-up study | 27.3 | 0 | 2 |
| Hypertension in pregnancy: Role of body mass index, insulin resistance, aldosterone, and calcium homeostasis | 27.3 | 0 | 2 |
| Accuracy of Tri-ponderal Mass Index and Body Mass Index in Estimating Insulin Resistance, Hyperlipidemia, Impaired Liver Enzymes or Thyroid Hormone Function and Vitamin D Levels in Children and Adolescents | 27.3 | 0 | 2 |
| Determinants of Metabolic Health Across Body Mass Index Categories in Central Europe: A Comparison Between Swiss and Czech Populations | 27.3 | 0 | 2 |
| SAT-102 Self-efficacy As A Predictor Of Weight Loss In Veterans With Obesity Participating In Medical Weight Management | 27.3 | 0 | 2 |
| Association between body mass index and insulin resistance in survivors of pediatric acute lymphoblastic leukemia | 27.3 | 0 | 2 |
| Higher Body Mass Index, Uric Acid Levels, and Lower Cholesterol Levels are Associated with Greater Weight Loss | 27.3 | 0 | 2 |
| Association of endocrine active environmental compounds with body mass index and weight loss following bariatric surgery | 27.3 | 0 | 2 |
| Association between the Thigh Muscle and Insulin Resistance According to Body Mass Index in Middle-Aged Korean Adults | 27.3 | 0 | 2 |
| Waist Circumference Rather than Body Mass Index is Better Indicator of Insulin Resistance in Type 2 Diabetes Mellitus in North Indian Population | 27.3 | 0 | 2 |
| Obesity Treatment: A Focus on Pharmacotherapy of Weight Management: Erratum | 27.3 | 0 | 2 |
| Insurance-Mandated Medical Weight Management Programs in Sleeve Gastrectomy Patients Do Not Improve Postoperative Weight Loss Outcomes at 1 Year | 27.3 | 0 | 2 |
| RS9939609 FTO gene variant modified weight loss and insulin resistance after a partial meal-replacement hypocaloric diet | 27.3 | 0 | 2 |
| Nondigestible Carbohydrates Affect Metabolic Health and Gut Microbiota in Overweight Adults after Weight Loss | 27.3 | 0 | 2 |
| The Novel Dual GIP and GLP-1 Receptor Agonist, Tirzepatide, Transiently Delays Gastric Emptying Similarly to Selective Long-Acting GLP-1 Receptor Agonists | 27.3 | 0 | 2 |
| Family Meal Practices and Weight Talk Between Adult Weight Management and Weight Loss Surgery Patients and Their Children | 27.3 | 0 | 2 |
| Emotion regulation strategies predict weight loss during an inpatient obesity treatment for adolescents | 27.3 | 0 | 2 |
| Group Education & Lifestyle Modification's Impact on Weight Loss & Quality Life of Patients With OA | 27.3 | 0 | 2 |
| Effect of Behavioral Weight Management Interventions Using Lifestyle mHealth Self-Monitoring on Weight Loss: A Systematic Review and Meta-Analysis | 27.3 | 0 | 2 |
| A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant | 27.3 | 0 | 2 |
| Body Mass Index-Adjusted Body Weight Loss Grading Predicts Overall Survival in Esophageal Squamous Cell Carcinoma Patients | 27.3 | 0 | 2 |
| Barriers and facilitators of successful weight loss during participation in behavioural weight management programmes: a protocol for a systematic review | 27.3 | 0 | 2 |
| Cardiorespiratory Fitness, Body Mass Index and Insulin Resistance in Healthy Adults | 27.3 | 0 | 2 |
| Weight loss during medical weight management does not predict weight loss after bariatric surgery: a retrospective cohort study | 27.3 | 0 | 2 |
| Serum level of A-kinase anchoring protein 1, negatively correlated with insulin resistance and body mass index, decreases slightly in people with newly diagnosed T2DM | 27.3 | 0 | 2 |
| Class 3 Obesity in a Multidisciplinary Metabolic Weight Management Program: The Effect of Preexisting Type 2 Diabetes on 6-Month Weight Loss | 27.3 | 0 | 2 |
| [POST MASSIVE WEIGHT LOSS BODY CONTOURING SURGERIES CONTRIBUTE SIGNIFICANTLY TO OBESITY TREATMENT] | 27.3 | 0 | 2 |
| Comment on: Weight loss during medical weight management does not predict weight loss after bariatric surgery: a retrospective cohort study | 27.3 | 0 | 2 |
| Weight loss, insulin resistance, and study design confound results in a meta-analysis of animal models of fatty liver | 27.3 | 0 | 2 |
| Synergistic association of high-sensitivity C-reactive protein and body mass index with insulin resistance in non-diabetic adults | 27.3 | 0 | 2 |
| A circadian rhythm-related MTNR1B genetic variant (rs10830963) modulates glucose metabolism and insulin resistance after body weight loss secondary to biliopancreatic diversion surgery | 27.3 | 0 | 2 |
| Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405 | 27.3 | 0 | 2 |
| Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis | 27.3 | 0 | 2 |
| Effect of a weight loss program on serum adiponectin and insulin resistance among overweight and obese premenopausal females | 27.3 | 0 | 2 |
| Web-based virtual reality to enhance behavioural skills training and weight loss in a commercial online weight management programme: The Experience Success randomized trial | 27.3 | 0 | 2 |
| Remote vs In Person Weight Loss Study | 27.3 | 0 | 2 |
| A randomized controlled trial to isolate the effects of fasting and energy restriction on weight loss and metabolic health in lean adults | 27.3 | 0 | 2 |
| tirzepatide | 27.3 | 0 | 2 |
| weight loss treatment | 27.3 | 0 | 2 |
| "Tubby, like a marshmallow" : the lived experiences of children and their parents as participants in a child weight management programme | 27.3 | 0 | 2 |
| Use of a non-dieting approach to support weight management patients to improve eating behaviours and dietary intake | 27.3 | 0 | 2 |
| Evaluation of a weight management program using the intuitive eating approach for clinically overweight and obese adults | 27.3 | 0 | 2 |
| Novel Combination of Exercise and Carbohydrate Restriction for Metabolic Health | 27.3 | 0 | 2 |
| Prevalence rates of metabolic health and body size phenotypes by different criteria and association with insulin resistance in a Maltese Caucasian population | 27.3 | 0 | 2 |
| LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept | 27.3 | 0 | 2 |
| Forearm Immobilization, Metabolic Health, and Nutrition | 27.3 | 0 | 2 |
| Self-Weighing for Adolescents Seeking Obesity Treatment | 27.3 | 0 | 2 |
| Understanding Variability in Behavioral Weight Loss Treatment Response in Young Women (Ready SET Health) | 27.3 | 0 | 2 |
| Total Joint Arthroplasty (TJA) Weight Loss Study | 27.3 | 0 | 2 |
| A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in Switzerland | 27.3 | 0 | 2 |
| Log2Lose: Incenting Weight Loss and Dietary Self-monitoring in Real-time to Improve Weight Management Among Adults With Obesity | 27.3 | 0 | 2 |
| Semaglutide Use in Elderly Obese Patients | 27.3 | 0 | 2 |
| Adipose methylome integrative-omic analyses reveal genetic and dietary metabolic health drivers and insulin resistance classifiers | 27.3 | 0 | 2 |
| The Niche of n-of-1 Trials in Precision Medicine for Weight Loss and Obesity Treatment: Back to the Future | 27.3 | 0 | 2 |
| Comparison of Weight Loss Between Consecutive Diabetic and Non-Diabetic Patients Enrolled in a Structured Weight Management Program—Data from the EMERALD Registry | 27.3 | 0 | 2 |
| Impact of body mass index in patulous Eustachian tube: Does rapid weight loss influence symptom improvement? | 27.3 | 0 | 2 |
| Weight Management Strategies of Successful Weight Maintainers Subsequent to Clinically Relevant Weight Loss | 27.3 | 0 | 2 |
| Liraglutide for Weight Management in the Real World: Significant Weight Loss Even if the Maximal Daily Dose Is Not Achieved | 27.3 | 0 | 2 |
| Review on Predictors of Weight Loss Maintenance after Successful Weight Loss in Obesity Treatment | 27.3 | 0 | 2 |
| Efficacy of Liraglutide: GLP 1 Receptor Agonist on Glycemic Control and Weight Loss among Patients with Type 2 Diabetes | 27.3 | 0 | 2 |
| Evaluation of an NCCN guideline-based weight management pathway on weight loss in female breast cancer patients. | 27.3 | 0 | 2 |
| 1124 Identifying Predictors of Weight Loss for Patients Enrolled in an Intensive Medical Weight Management Program | 27.3 | 0 | 2 |
| Abstract 3281: The association between body mass index (BMI) and risk of pancreatic cancer depends on age at BMI assessment | 27.3 | 0 | 2 |
| Abstract 3285: Body mass index, weight loss, and progression and mortality in metastatic colorectal cancer: Results from CALGB/SWOG 80405 (Alliance) | 27.3 | 0 | 2 |
| Insulin resistance, systemic and regional inflammation in subcutaneous adipose tissue during weight loss in a population with obesity | 27.3 | 0 | 2 |
| Sa1627 – Effect of a Ketogenic Weight Loss Protocol on Liver Enzymes, Fibrosis Scores, and Features of Insulin Resistance in Nash Patients | 27.3 | 0 | 2 |
| Relationship of monocyte chemoattractant protein 1 (MCP-1) with insulin resistance and body mass index, but not with thermogenetic hormones in obesity | 27.3 | 0 | 2 |
| Bitter almond gum reduces body mass index, serum triglyceride, hyperinsulinemia and insulin resistance in overweight subjects with hyperlipidemia | 27.3 | 0 | 2 |
| 101. The Genetic Risk For Body Mass Index And Weight Loss Behaviors | 27.3 | 0 | 2 |
| A 10-Week Pedometer-Based Walking Program Induced Weight Loss and Improved Metabolic Health in Community-Dwelling Adults | 27.3 | 0 | 2 |
| Body mass index and weight loss as risk factors for poor outcomes in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Insulin Resistance and Abnormalities in Blood Values of Icelandic Children Receiving Obesity Treatment | 27.3 | 0 | 2 |
| THE ASSOCIATION OF INSULIN RESISTANCE WITH BODY MASS INDEX AND BODY FAT PERCENTAGES IN NON-DIABETIC OBESE WOMEN | 27.3 | 0 | 2 |
| Predictors of weight loss in a Secondary Care Tier 3 Specialist Weight Management Service Following Modifications due to the COVID-19 Pandemic | 27.3 | 0 | 2 |
| Su1995 - Pre-Operative Body Mass Index Predicts Weight Loss two Years after Sleeve Gastrectomy but Does not Affect Comorbidity Resolution | 27.3 | 0 | 2 |
| Impact of short term weight loss (very low calorie diet vs bariatric surgery) on hepatic insulin resistance and plasma lipidomic profile | 27.3 | 0 | 2 |
| Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials | 27.3 | 0 | 2 |
| Evaluation of a new causal chain model for predicting embedded psychosocial and behavioral relationships in a community‐based obesity treatment seeking maintained weight loss | 27.3 | 0 | 2 |
| Q135239885 | 27.3 | 0 | 2 |
| Q135289815 | 27.3 | 0 | 2 |
| Q135970336 | 27.3 | 0 | 2 |
| Q136788425 | 27.3 | 0 | 2 |
| Weight Management Cooking: Healthy Recipes for Weight Loss | 27.3 | 0 | 2 |
| Trimi Health | 27.3 | 0 | 2 |
| Go Leaner | 27.3 | 0 | 2 |
| Harbor | 27.3 | 0 | 2 |
| Time | 21.4 | 1 | 0 |
| Time Person of the Year | 21.4 | 1 | 0 |
| Oregon Health and Science University | 21.4 | 1 | 0 |
| Terence McKenna | 21.4 | 1 | 0 |
| James Rothman | 21.4 | 1 | 0 |
| Q483551 | 21.4 | 1 | 0 |
| The World's Billionaires | 21.4 | 1 | 0 |
| Eli Lilly and Company | 21.4 | 1 | 0 |
| Google Lively | 21.4 | 1 | 0 |
| Palfinger | 21.4 | 1 | 0 |
| Novo Nordisk | 21.4 | 1 | 0 |
| Johns Hopkins School of Medicine | 21.4 | 1 | 0 |
| Slim Fast | 21.4 | 1 | 0 |
| University of Texas Medical Branch | 21.4 | 1 | 0 |
| Forbes | 21.4 | 1 | 0 |
| The World's Most Powerful People | 21.4 | 1 | 0 |
| Forbes Global 2000 | 21.4 | 1 | 0 |
| Pennsylvania Hospital | 21.4 | 1 | 0 |
| Mike Lazaridis | 21.4 | 1 | 0 |
| Johns Hopkins Hospital | 21.4 | 1 | 0 |
| Mount Sinai Hospital | 21.4 | 1 | 0 |
| The Atlantic | 21.4 | 1 | 0 |
| Walgreens | 21.4 | 1 | 0 |
| CVS Pharmacy | 21.4 | 1 | 0 |
| UCLA Ronald Reagan Medical Center | 21.4 | 1 | 0 |
| Forbes 400 | 21.4 | 1 | 0 |
| WUMAG elevant | 21.4 | 1 | 0 |
| AdventHealth Porter | 21.4 | 1 | 0 |
| AdventHealth Orlando | 21.4 | 1 | 0 |
| AdventHealth | 21.4 | 1 | 0 |
| Johns Hopkins All Children's Hospital | 21.4 | 1 | 0 |
| Arthur L. Jenkins | 21.4 | 1 | 0 |
| Community Memorial Hospital | 21.4 | 1 | 0 |
| Corinne Goldsmith Dickinson Center for Multiple Sclerosis | 21.4 | 1 | 0 |
| Donald Engelman | 21.4 | 1 | 0 |
| AdventHealth East Orlando | 21.4 | 1 | 0 |
| AdventHealth Celebration | 21.4 | 1 | 0 |
| AdventHealth Sebring | 21.4 | 1 | 0 |
| AdventHealth Lake Placid | 21.4 | 1 | 0 |
| AdventHealth Wauchula | 21.4 | 1 | 0 |
| Franciscan Skemp Medical Center | 21.4 | 1 | 0 |
| Froedtert Hospital | 21.4 | 1 | 0 |
| Galveston National Laboratory | 21.4 | 1 | 0 |
| Gordon M. Shepherd | 21.4 | 1 | 0 |
| HealthPartners | 21.4 | 1 | 0 |
| Hermetic Journal | 21.4 | 1 | 0 |
| Heyday Records | 21.4 | 1 | 0 |
| Hospital of the University of Pennsylvania | 21.4 | 1 | 0 |
| Howard County General Hospital | 21.4 | 1 | 0 |
| Is Google Making Us Stupid? | 21.4 | 1 | 0 |
| UCLA Jules Stein Eye Institute | 21.4 | 1 | 0 |
| AdventHealth Littleton | 21.4 | 1 | 0 |
| MDVIP | 21.4 | 1 | 0 |
| Mayo School of Health Sciences | 21.4 | 1 | 0 |
| Medical News Today | 21.4 | 1 | 0 |
| AdventHealth Ocala | 21.4 | 1 | 0 |
| MyFitnessPal | 21.4 | 1 | 0 |
| Nathaniel Raymond | 21.4 | 1 | 0 |
| Oregon Health & Science University School of Dentistry | 21.4 | 1 | 0 |
| Oregon Health & Science University Hospital | 21.4 | 1 | 0 |
| Overlake Hospital Medical Center | 21.4 | 1 | 0 |
| AdventHealth Parker | 21.4 | 1 | 0 |
| Mass General Brigham | 21.4 | 1 | 0 |
| Penn Presbyterian Medical Center | 21.4 | 1 | 0 |
| Perelman Center for Advanced Medicine | 21.4 | 1 | 0 |
| Red Wing Medical Center | 21.4 | 1 | 0 |
| AdventHealth Redmond | 21.4 | 1 | 0 |
| Scheie Eye Institute | 21.4 | 1 | 0 |
| AdventHealth Shawnee Mission | 21.4 | 1 | 0 |
| Sibley Memorial Hospital | 21.4 | 1 | 0 |
| Sofia Frangou | 21.4 | 1 | 0 |
| Stanford Hospital and Clinics | 21.4 | 1 | 0 |
| Stanford University Medical Center | 21.4 | 1 | 0 |
| UCLA Santa Monica Medical Center | 21.4 | 1 | 0 |
| UCSF Medical Center | 21.4 | 1 | 0 |
| University of Pennsylvania Health System | 21.4 | 1 | 0 |
| University of Virginia Health System | 21.4 | 1 | 0 |
| University of Virginia School of Medicine | 21.4 | 1 | 0 |
| Victor Velculescu | 21.4 | 1 | 0 |
| William D. Steers | 21.4 | 1 | 0 |
| Forbes' list of the world's highest-paid athletes | 21.4 | 1 | 0 |
| AdventHealth Lake Wales | 21.4 | 1 | 0 |
| Johns Hopkins Bayview Medical Center | 21.4 | 1 | 0 |
| Fred R. Volkmar | 21.4 | 1 | 0 |
| Yale Journal of Biology and Medicine | 21.4 | 1 | 0 |
| Q16117390 | 21.4 | 1 | 0 |
| Mohamed Mansour | 21.4 | 1 | 0 |
| list of Walmart brands | 21.4 | 1 | 0 |
| Immanuel St. Joseph's | 21.4 | 1 | 0 |
| Healthline | 21.4 | 1 | 0 |
| Suburban Hospital | 21.4 | 1 | 0 |
| Medpace | 21.4 | 1 | 0 |
| The Thriving Cult of Greed and Power | 21.4 | 1 | 0 |
| Vollum Institute | 21.4 | 1 | 0 |
| Edward Thomas Ryan | 21.4 | 1 | 0 |
| Oregon Health and Science University Center for Women's Health | 21.4 | 1 | 0 |
| Teladoc | 21.4 | 1 | 0 |
| Godfrey D. Pearlson | 21.4 | 1 | 0 |
| William G. Nelson | 21.4 | 1 | 0 |
| Charles Limb | 21.4 | 1 | 0 |
| Joseph John Klimek | 21.4 | 1 | 0 |
| major depressive disorder | 17.2 | 0 | 1 |
| body mass index | 17.2 | 0 | 1 |
| anorexia nervosa | 17.2 | 0 | 1 |
| overweight | 17.2 | 0 | 1 |
| bariatric surgery | 17.2 | 0 | 1 |
| hyperemesis gravidarum | 17.2 | 0 | 1 |
| glucagon-like peptide-1 | 17.2 | 0 | 1 |
| emaciation | 17.2 | 0 | 1 |
| metabolic syndrome | 17.2 | 0 | 1 |
| weight loss | 17.2 | 0 | 1 |
| reducing diet | 17.2 | 0 | 1 |
| weight cycling | 17.2 | 0 | 1 |
| insulin resistance | 17.2 | 0 | 1 |
| anti-obesity medication | 17.2 | 0 | 1 |
| William Banting | 17.2 | 0 | 1 |
| bariatric medicine | 17.2 | 0 | 1 |
| low-glycemic diet | 17.2 | 0 | 1 |
| Cabbage soup diet | 17.2 | 0 | 1 |
| The China Study | 17.2 | 0 | 1 |
| healthy weight loss | 17.2 | 0 | 1 |
| glucose intolerance | 17.2 | 0 | 1 |
| type 2 diabetes | 17.2 | 0 | 1 |
| Scarsdale diet | 17.2 | 0 | 1 |
| Valérie Orsoni | 17.2 | 0 | 1 |
| Extreme Weight Loss | 17.2 | 0 | 1 |
| ileitis | 17.2 | 0 | 1 |
| weight loss product | 17.2 | 0 | 1 |
| CalorieKing | 17.2 | 0 | 1 |
| Cigarette smoking for weight loss | 17.2 | 0 | 1 |
| Eva Orsmond | 17.2 | 0 | 1 |
| Eskatrol | 17.2 | 0 | 1 |
| GSK716155 | 17.2 | 0 | 1 |
| glucagon-like peptide-1 agonist | 17.2 | 0 | 1 |
| HAIR-AN syndrome | 17.2 | 0 | 1 |
| Hard keeper | 17.2 | 0 | 1 |
| Herbal Magic | 17.2 | 0 | 1 |
| Cuestión de peso | 17.2 | 0 | 1 |
| homeostatic model assessment | 17.2 | 0 | 1 |
| ileocolitis | 17.2 | 0 | 1 |
| cachexia | 17.2 | 0 | 1 |
| Naturhouse | 17.2 | 0 | 1 |
| Template:BMI | 17.2 | 0 | 1 |
| My Weight Loss Coach | 17.2 | 0 | 1 |
| National Weight Control Registry | 17.2 | 0 | 1 |
| Nutrisystem | 17.2 | 0 | 1 |
| Category:Weight loss | 17.2 | 0 | 1 |
| Online weight loss plans | 17.2 | 0 | 1 |
| PEERtrainer | 17.2 | 0 | 1 |
| Revision weight loss surgery | 17.2 | 0 | 1 |
| Skinny Bitch | 17.2 | 0 | 1 |
| Slimming World | 17.2 | 0 | 1 |
| The Weight-Loss Cure "They" Don't Want You to Know About | 17.2 | 0 | 1 |
| toning exercises | 17.2 | 0 | 1 |
| Trim and Fit | 17.2 | 0 | 1 |
| Weight Loss | 17.2 | 0 | 1 |
| Weight Loss | 17.2 | 0 | 1 |
| Weight Wins | 17.2 | 0 | 1 |
| weight cutting | 17.2 | 0 | 1 |
| Weight loss coaching | 17.2 | 0 | 1 |
| Weight loss effects of water | 17.2 | 0 | 1 |
| Wellspring camps | 17.2 | 0 | 1 |
| Category:Weight loss companies | 17.2 | 0 | 1 |
| Category:GLP-1 receptor agonists | 17.2 | 0 | 1 |
| Charles D'Angelo | 17.2 | 0 | 1 |
| secondary diabetes | 17.2 | 0 | 1 |
| Eat to Live | 17.2 | 0 | 1 |
| Weight loss | 17.2 | 0 | 1 |
| Health Management Resources | 17.2 | 0 | 1 |
| Retrofit | 17.2 | 0 | 1 |
| weight management | 17.2 | 0 | 1 |
| BMIQ1 | 17.2 | 0 | 1 |
| BMIQ2 | 17.2 | 0 | 1 |
| BMIQ3 | 17.2 | 0 | 1 |
| BMIQ5 | 17.2 | 0 | 1 |
| BMIQ6 | 17.2 | 0 | 1 |
| Wtlr1 | 17.2 | 0 | 1 |
| Wtlr2 | 17.2 | 0 | 1 |
| Bmnx | 17.2 | 0 | 1 |
| Wtlr3 | 17.2 | 0 | 1 |
| Wtlr4 | 17.2 | 0 | 1 |
| Type 3 diabetes | 17.2 | 0 | 1 |
| typhoidal tularemia | 17.2 | 0 | 1 |
| gastroduodenal Crohn's disease | 17.2 | 0 | 1 |
| lung carcinoma | 17.2 | 0 | 1 |
| BMIQ13 | 17.2 | 0 | 1 |
| BMIQ8 | 17.2 | 0 | 1 |
| BMIQ15 | 17.2 | 0 | 1 |
| BMIQ14 | 17.2 | 0 | 1 |
| Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin | 17.2 | 0 | 1 |
| Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat | 17.2 | 0 | 1 |
| The use of a Cissus quadrangularis formulation in the management of weight loss and metabolic syndrome | 17.2 | 0 | 1 |
| High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity | 17.2 | 0 | 1 |
| A New Body Shape Index Predicts Mortality Hazard Independently of Body Mass Index | 17.2 | 0 | 1 |
| Reduced Serotonin Reuptake Transporter (SERT) Function Causes Insulin Resistance and Hepatic Steatosis Independent of Food Intake | 17.2 | 0 | 1 |
| High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse | 17.2 | 0 | 1 |
| alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population | 17.2 | 0 | 1 |
| Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index | 17.2 | 0 | 1 |
| chromosome 16p11.2 deletion syndrome, 220kb | 17.2 | 0 | 1 |
| Does weight loss improve semen quality and reproductive hormones? Results from a cohort of severely obese men | 17.2 | 0 | 1 |
| DHEA administration and exercise training improves insulin resistance in obese rats | 17.2 | 0 | 1 |
| High-Protein Weight Loss Diets and Purported Adverse Effects: Where is the Evidence? | 17.2 | 0 | 1 |
| Adolescent dietary patterns in Fiji and their relationships with standardized body mass index | 17.2 | 0 | 1 |
| Intramyocellular lipid kinetics and insulin resistance | 17.2 | 0 | 1 |
| Nutrient adequacy during weight loss interventions: a randomized study in women comparing the dietary intake in a meal replacement group with a traditional food group | 17.2 | 0 | 1 |
| Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle East and native Swedish women: a cross-sectional study | 17.2 | 0 | 1 |
| Body mass index, sexual behaviour, and sexually transmitted infections: an analysis using the NHANES 1999-2000 data | 17.2 | 0 | 1 |
| Posttransplantation malignancy in a patient presenting with weight loss and changed bowel habits: a case report | 17.2 | 0 | 1 |
| The A54T polymorphism at the intestinal fatty acid binding protein 2 is associated with insulin resistance in glucose tolerant Caucasians | 17.2 | 0 | 1 |
| Evolutionary origins of insulin resistance: a behavioral switch hypothesis | 17.2 | 0 | 1 |
| Emphasising Personal Investment Effects Weight Loss and Hedonic Thoughts about Food after Obesity Surgery | 17.2 | 0 | 1 |
| Insulin Resistance in Patients with Chronic Kidney Disease | 17.2 | 0 | 1 |
| Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions | 17.2 | 0 | 1 |
| High-intensity intermittent exercise and fat loss | 17.2 | 0 | 1 |
| The Use of Garcinia Extract (Hydroxycitric Acid) as a Weight loss Supplement: A Systematic Review and Meta-Analysis of Randomised Clinical Trials | 17.2 | 0 | 1 |
| The use of green coffee extract as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials | 17.2 | 0 | 1 |
| Intentional weight loss and dose reductions of anti-diabetic medications--a retrospective cohort study | 17.2 | 0 | 1 |
| Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss | 17.2 | 0 | 1 |
| The association of a SNP upstream of INSIG2 with body mass index is reproduced in several but not all cohorts | 17.2 | 0 | 1 |
| Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension | 17.2 | 0 | 1 |
| Diet in the management of weight loss | 17.2 | 0 | 1 |
| New Therapeutic Strategies and Drug Candidates for Neurodegenerative Diseases: p53 and TNF- Inhibitors, and GLP-1 Receptor Agonists | 17.2 | 0 | 1 |
| Inflammation and insulin resistance | 17.2 | 0 | 1 |
| Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss | 17.2 | 0 | 1 |
| Obesity, Inflammation, and Insulin Resistance | 17.2 | 0 | 1 |
| Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults | 17.2 | 0 | 1 |
| Severe obesity: Investigating the socio-demographics within the extremes of body mass index | 17.2 | 0 | 1 |
| Cognitive-Behavioral Therapy for Weight Management and Eating Disorders in Children and Adolescents | 17.2 | 0 | 1 |
| Body mass index and mortality in heart failure: A meta-analysis | 17.2 | 0 | 1 |
| Body mass index and the risk of gout: a systematic review and dose–response meta-analysis of prospective studies | 17.2 | 0 | 1 |
| Genetic studies of body mass index yield new insights for obesity biology | 17.2 | 0 | 1 |
| The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance | 17.2 | 0 | 1 |
| An approach to the management of unintentional weight loss in elderly people | 17.2 | 0 | 1 |
| Obesity medicine | 17.2 | 0 | 1 |
| Sleep duration and body mass index in a rural population | 17.2 | 0 | 1 |
| Body mass index versus dual energy x-ray absorptiometry-derived indexes: predictors of cardiovascular and diabetic disease risk factors | 17.2 | 0 | 1 |
| Job strain and changes in the body mass index among working women: a prospective study | 17.2 | 0 | 1 |
| Association between body mass index and acute traumatic workplace injury in hourly manufacturing employees | 17.2 | 0 | 1 |
| Workplace-Based Participatory Approach to Weight Loss for Correctional Employees | 17.2 | 0 | 1 |
| Household solid fuel use, body mass index, and pulmonary function in an urban population in Shanghai, China | 17.2 | 0 | 1 |
| Influence of body mass index and work activity on the prevalence of median mononeuropathy at the wrist | 17.2 | 0 | 1 |
| Inverse association between toenail arsenic and body mass index in a population of welders | 17.2 | 0 | 1 |
| Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss | 17.2 | 0 | 1 |
| Steps to health employee weight management randomized control trial: short-term follow-up results | 17.2 | 0 | 1 |
| Evaluation of body mass index, pre-vaccination serum progesterone levels and anti-anthrax protective antigen immunoglobulin G on injection site adverse events following anthrax vaccination in women | 17.2 | 0 | 1 |
| excess skin | 17.2 | 0 | 1 |
| A clinical trial on weight loss among truck drivers | 17.2 | 0 | 1 |
| Impact of missing data for body mass index in an epidemiologic study | 17.2 | 0 | 1 |
| Associations of body mass index with meniscal tears | 17.2 | 0 | 1 |
| Physical activity and body mass index: the contribution of age and workplace characteristics | 17.2 | 0 | 1 |
| Body mass index, playing position, race, and the cardiovascular mortality of retired professional football players | 17.2 | 0 | 1 |
| The steps to health employee weight management randomized control trial: rationale, design and baseline characteristics | 17.2 | 0 | 1 |
| Body mass index estimates using a categorical body weight variable: A cross-sectional secondary data analysis | 17.2 | 0 | 1 |
| Associations between Psychological Distress and Body Mass Index among Law Enforcement Officers: The National Health Interview Survey 2004-2010 | 17.2 | 0 | 1 |
| Body weight management in overweight and obese breast cancer survivors | 17.2 | 0 | 1 |
| Psychosocial interventions for the maintenance of weight loss in obese adults | 17.2 | 0 | 1 |
| Commercial weight loss products and services for obese and overweight adults | 17.2 | 0 | 1 |
| Zinc supplementation for the prevention of type 2 diabetes mellitus in adults with insulin resistance | 17.2 | 0 | 1 |
| Surgery for weight loss in adults | 17.2 | 0 | 1 |
| Health, not weight loss, focused programmes versus conventional weight loss programmes for cardiovascular risk factors | 17.2 | 0 | 1 |
| Chinese herbal medicines for weight loss | 17.2 | 0 | 1 |
| Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis | 17.2 | 0 | 1 |
| Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis | 17.2 | 0 | 1 |
| Transtheoretical model stages of change for dietary and physical exercise modification in weight loss management for overweight and obese adults | 17.2 | 0 | 1 |
| Interactive computer-based interventions for weight loss or weight maintenance in overweight or obese people | 17.2 | 0 | 1 |
| Weight loss interventions for chronic asthma | 17.2 | 0 | 1 |
| Commercial weight loss products and services for obese and overweight adults | 17.2 | 0 | 1 |
| Green tea for weight loss and weight maintenance in overweight or obese adults | 17.2 | 0 | 1 |
| Weight loss intervention through lifestyle modification or pharmacotherapy for obstructive sleep apnoea in adults | 17.2 | 0 | 1 |
| Interventions for fatigue and weight loss in adults with advanced progressive illness | 17.2 | 0 | 1 |
| Weight loss interventions for chronic asthma | 17.2 | 0 | 1 |
| Transtheoretical model for dietary and physical exercise modification in weight loss management for overweight and obese adults | 17.2 | 0 | 1 |
| Green tea for weight loss and weight maintenance in overweight or obese adults | 17.2 | 0 | 1 |
| Interventions for fatigue and weight loss in adults with advanced progressive illness | 17.2 | 0 | 1 |
| Computer-based interventions for weight loss or weight maintenance in overweight or obese people | 17.2 | 0 | 1 |
| Transtheoretical model for dietary and physical exercise modification in weight loss management for overweight and obese adults | 17.2 | 0 | 1 |
| Chinese herbal medicines for weight loss | 17.2 | 0 | 1 |
| Psychosocial interventions for the maintenance of weight loss in obese adults | 17.2 | 0 | 1 |
| Weight loss for primary prevention of stroke in people with overweight or obesity | 17.2 | 0 | 1 |
| Long-term non-pharmacological weight loss interventions for adults with prediabetes | 17.2 | 0 | 1 |
| Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus | 17.2 | 0 | 1 |
| Anabolic steroids for the treatment of weight loss in HIV-infected individuals | 17.2 | 0 | 1 |
| Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis | 17.2 | 0 | 1 |
| Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis | 17.2 | 0 | 1 |
| Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus | 17.2 | 0 | 1 |
| Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus | 17.2 | 0 | 1 |
| MR-PheWAS: hypothesis prioritization among potential causal effects of body mass index on many outcomes, using Mendelian randomization | 17.2 | 0 | 1 |
| Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes | 17.2 | 0 | 1 |
| Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance | 17.2 | 0 | 1 |
| Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes | 17.2 | 0 | 1 |
| Correlation of maternal serum fetuin/alpha2-HS-glycoprotein concentration with maternal insulin resistance and anthropometric parameters of neonates in normal pregnancy and gestational diabetes | 17.2 | 0 | 1 |
| Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance | 17.2 | 0 | 1 |
| Novel hormone-regulated genes in visceral adipose tissue: cloning and identification of proinflammatory cytokine-like mouse and human MEDA-7: implications for obesity, insulin resistance and the metabolic syndrome | 17.2 | 0 | 1 |
| S6K directly phosphorylates IRS-1 on Ser-270 to promote insulin resistance in response to TNF-(alpha) signaling through IKK2 | 17.2 | 0 | 1 |
| Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes | 17.2 | 0 | 1 |
| The transcription factor TFAP2B is associated with insulin resistance and adiposity in healthy adolescents | 17.2 | 0 | 1 |
| Membrane glycoprotein PC-1 and insulin resistance in non-insulin-dependent diabetes mellitus | 17.2 | 0 | 1 |
| Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis | 17.2 | 0 | 1 |
| Phosphoinositide signalling links O-GlcNAc transferase to insulin resistance | 17.2 | 0 | 1 |
| An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance | 17.2 | 0 | 1 |
| Human apolipoprotein D overexpression in transgenic mice induces insulin resistance and alters lipid metabolism | 17.2 | 0 | 1 |
| The expression of inhibin beta B is high in human adipocytes, reduced by weight loss, and correlates to factors implicated in metabolic disease | 17.2 | 0 | 1 |
| Spexin is a novel human peptide that reduces adipocyte uptake of long chain fatty acids and causes weight loss in rodents with diet‐induced obesity | 17.2 | 0 | 1 |
| Association of body mass index with facial dimensions for defining respirator fit test panels | 17.2 | 0 | 1 |
| A syndrome of insulin resistance resembling leprechaunism in five sibs of consanguineous parents | 17.2 | 0 | 1 |
| Insulin and insulin resistance. | 17.2 | 0 | 1 |
| The Use of Nonprescription Weight Loss Products Among Female Basketball, Softball, and Volleyball Athletes from NCAA Division I Institutions: Issues and Concerns. | 17.2 | 0 | 1 |
| The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance | 17.2 | 0 | 1 |
| Hexosamines, insulin resistance, and the complications of diabetes: current status | 17.2 | 0 | 1 |
| Stable behaviors associated with adults' 10-year change in body mass index and likelihood of gain at the waist | 17.2 | 0 | 1 |
| Missing data in randomized clinical trials for weight loss: scope of the problem, state of the field, and performance of statistical methods | 17.2 | 0 | 1 |
| Fetal and early life growth and body mass index from birth to early adulthood in 1958 British cohort: longitudinal study | 17.2 | 0 | 1 |
| Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance | 17.2 | 0 | 1 |
| Fructose, insulin resistance, and metabolic dyslipidemia | 17.2 | 0 | 1 |
| Thermodynamics of weight loss diets | 17.2 | 0 | 1 |
| Deficiency of phosphofructo-1-kinase/muscle subtype in humans impairs insulin secretion and causes insulin resistance | 17.2 | 0 | 1 |
| Effect of excessive water intake on body weight, body mass index, body fat, and appetite of overweight female participants | 17.2 | 0 | 1 |
| Reversal of hypertriglyceridemia, fatty liver disease, and insulin resistance by a liver-targeted mitochondrial uncoupler | 17.2 | 0 | 1 |
| Mechanism of free fatty acid-induced insulin resistance in humans | 17.2 | 0 | 1 |
| Liposuction does not achieve metabolic benefits of weight loss | 17.2 | 0 | 1 |